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Thirteen’s a charm for ISLAR ’95
13th Annual Symposium Features New Sessions & Record Breaking Attendance. It was a memorable year for
the International Symposium on Laboratory Automation & Robotics (ISLAR ’95). This year’s symposium--the lucky
number 13--enhanced ISLAR’s reputation as the pre-eminent conference on laboratory automation and robotics, with
features including: a 25 increase to 500 attendees, 95 podium and poster presentations, plus a first-ever special session
focused on combinatorial chemistry.
New Emphasis on Management & Drug Discovery Issues. From keynote speeches and feature presentations to
interactive discussion groups and technical poster presentations, ISLAR ’95 provided a forum for the latest developments
in the burgeoning field of laboratory automation and robotics. In addition, new emphasis on two of the most pressing
issues facing scientists and laboratory technicians today--Managing Laboratory Automation and Automating Drug
Discovery--was instituted. Three comprehensive.sessions were conducted to accommodate presentations on managerial
issues, as well as four sessions and a special roundtable discussion on the topic of automated drug discovery.
New Application & Company Luncheons Highly Successful. The three day symposium attracted a world renowned
group ofscientists that included representatives from 17 countries and 150 different organizations. To facilitate interaction
between attendees, ISLAR offered two special luncheon programmes--one that grouped participants by application
area and a special company-specific luncheon. Both provided colleagues, who share common interests and experience,
with a forum to interact and network with peers.
As always, another symposium highligh.t was a reception at Zymark Center, Hopkinton, MA, that featured an introduction
to Zymark’s expanded customer service capabilities, including demonstrations of a customer service web-site,
video-conferencing support services, plus enhanced validation and field application capabilities. The reception also
featured demonstrations of the latest developments in robotic technology--Zymark unveiled a number of exciting new
products, including the MultiDose Automated Dissolution Testing Workstation, an organic Synthesis System and the
RapidTrace SPE Workstation.
The 1996 ISLAR will be held in Boston, MA from 20-23 October, 1996. Paper and Poster submissions are being
accepted now. For more information on the symposium, contact Chris O’Neil at 508 435 9500, send an E-mail to
islar@zymark.com or visit the ISLAR pages at http://www.zymark.com
Dr James N. Little
PLENARY SESSION
Re-engineering the laboratory
Francis H. Zenie
Zymark Corporation, Hopkinton, MA, USA
Our organizations are changing more rapidly than ever
before--and the consequences range from prosperity--to
fragile survival--to economic failure. Re-engineering is a
process through which we can initiate and direct change
rather than react to changes created by others. Re-
engineering business is not new, yet it is timely to meet
today’s challenges.
The two primary forces driving these changes include:
Informed customers--informed customers demand more
value and stimulate competition. As both individual
consumers and business purchasers, we are better
educated and more demanding about receiving value
for our investments. As providers of products and
services, therefore, we must re-earn customers’
business by providing innovative new products and
greater value.
(2) Information Technology--IT is both a primary cause
and an enabling technology helping to adapt to
change. IT enables organizations to shift from
inefficient hierarchies to highly efficient teams work-
ing on high leverage opportunities. Ever increasing
globalization is a strategic opportunity made possible
through advances in IT.
Both of these driving forces are irreversible and relentless,
that is they will never return to the past. Regulation, on
the other hand, is often a political, and even emotional,
driving force. We have seen many examples where the
desired benefits of regulation are better attained through
customer education and economic incentives.
Science cannot separate itselffrom business and economics.
Science creates the technology which drives our most
robust businesses. As competitive, consumer and regulatory
pressures force business to improve quality and product-
ivity, science must lead, or at least enable, the bold steps
ahead.
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Our goal is to increase productivity--that is create more
economic value for each unit of cost. Only when survival
is at stake, must we place cost or people reduction ahead
ofincreasing productivity. Wherever possible, people and
automation should be teamed for productivity.
Mangement’s role continues to change. In the early phase
of the industrial revolution, managers existed to control
workers who performed physical tasks. Over time physical
work was transferred to machines and workers gained
more education to become knowledge workers. Expert
knowledge workers became managers to manage special-
ized functions. Organizations were structured as hier-
archies to maintain control and facilitate the flow of
information. Managers focused on specialized tasks rather
than whole processes which produced value. It is no
wonder that serving customers got lost.
Today’s managers lead and facilitate knowledge workers.
Effective managers delegate work to individuals and
teams and then stimulate innovation and change.
Keynote: The new face of drug discovery with
robotics and screening
Prabhavathi B. Fernandes
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton,
:vj, us
The cloning and identification ofnew genes as targets for
drug discovery have been enhanced greatly through new
methods in biotechnology and DNA sequencing. Coupled
with this novel target discovery is the urgent need for the
pharmaceutical industry to develop innovative drugs for
new therapeutic targets. New approaches to screen design
have resulted in sensitive and rapid screens which are
suited to automation and robotics. Rapid identification
of new leads within weeks of screen design is possible
through the screening of synthetic collections, combin-
atorial chemistry libraries, as well as diverse natural
product samples. The direct delivery of data from
automated instrumentation to computer data bases has
made the identification and sorting of leads possible.
Through the use ofrobotics and automation, high through-
put screening can accommodate thousands ofsamples per
day and the identification of leads results within weeks of
screening. Thus, new targets can now be cycled through
screens, resulting in rapid lead identification for exploratory
and drug discovery research.
However, the biological matrix cannot be analysed
directly, and the speed ofsample preparation has become
the rate-limiting step in achieving high throughput assays.
The need for automation has now shifted away from
analytical instrumentation towards the sample preparation
step. In particular, solid-phase extraction has seen a major
increase as the method of choice for sample preparation.
It has been of particular importance in the analysis of
peptides and biotechnology molecules where solvent
extraction techniques that are widely used for small
molecule drug analysis are not always possible.
Commercial automated sample preparation instrumenta-
tion for the bioanalytical chemist is not widely available,
and the need to design an instrument specifically for this
purpose became apparent. Through a series of meetings
aimed at defining the process of sample preparation, and
exploring all of the desirable features for analysis of
biological matrices, a prototype instrument was con-
structed. This prototype was set up in a drug metabolism
laboratory and thoroughly evaluated. Through collabor-
ative teamwork, the instrument and its controlled software
were modified and ’Rapid Trace’was born.
The initial response to Rapid Trace by the laboratory
personnel has been very positive, and it has demonstrated
the potential to increase the productivity of the laboratory
for both methods development and sample analysis. The
system has been validated as part ofthe analytical method,
and shows superior reproducibility over manual SPE tech-
niques for the assays evaluated.
DRUG DISCOVERY
High throughput screening in a small biotech
environment
Michelle A. J. Palmer
Genetics Institute, Cambridge, MA, USA
High throughput screening in a small biotech group or
company shares many of the hurdles found in a large
pharmaceutical screening setting, but there are a number
of issues that are unique. These areas were highlighted in
this presentation and a perspective was given on what is
involved in implementing a HTS effort.
An automated solution for compound weighing,
dissolution and distribution
Keynote: Automation breakthrough for bioana-
lytical extractions
R. John Stubbs
Bioanalytical Methods, Drug Metabolism, The R. W. Johnson
Pharmaceutical Research Institute, Spring House, PA and Raritan,
vj, USA
The explosive growth of analytical technology in recent
years has provided the bioanalytical chemist with the
power to measure drugs and their metabolites in biological
fluids at extremely low concentrations. With the advent
of high specificity assays, there is often little or no
endogenous interference from the biological matrix.
John Babiak and Linda Heydt
Robotics and Automation Research, Wyeth-Ayerst Research,
Princeton, NJ 08543, USA
An integral part of any pharmaceutical automated
screening effort is the availability of a large number of
test compounds in an assay-ready format. The most
typical arrangement is to dissolve compounds in a
common solvent, such as DMSO, and distribute them
into microtitre plates for future use. The data generated
by this process include the identity of each compound,
the quantity ofeach compound dispensed, its final concen-
tration in solution, the ultimate plate and well location
of each compound and the volume of solution distributed
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into each plate. To meet expected future needs for com-
pound sourcing. The authors developed a single automated
system, that fits on a 6 x 10 ft laboratory bench, in
collaboration with Sagian, Inc.
The primary commercial hardware consists of an HP
ORCA robotic arm on a 3 m track, Tecan 8051 and 5051
diluters, two Zebra 105 bar code printer/applicators, three
Symbol bar code readers, two Hamilton syringe pumps
and a Mettler AT200 balance. Custom components
engineered by Sagian include a microtitre plate elevator,
a vial rack elevator and a microtitre plate sealer. Com-
munication is maintained by a Sagian IID; the robot is
controlled by HP-MDS and data management is handled
by MS-ACCESS.
The essence ofthe approach was to develop a single system
to weigh, dilute and dissolve compounds and then
distribute them into microtitre plates with minimal
human involvement. Three steps are required to generate
the desired microtitre plates of compounds. First, the
system individually bar codes empty amber vials and
determines the tare weight of each. Second, an approxi-
mate amount of compound is transferred manually into
each tared vial at a remote log-in station and the identity
of each compound is transirred manually in each vial by
reading bar codes. Third, the vials containing compounds
are returned to the automated system where compound
weights are determined, solvent is added and compounds
are automatically transferred to ’mother’ and ’daughter’
plates which are then bar coded and sealed by the
system.
The integrated system described will increase the authors’
laboratory’s capability to provide dissolved compounds
for future screens without an increase in the labour
involved in compound handling. Although many of the
steps involved in compound sourcing can be performed
by small workstations, and a few groups have described
large integrated systems, the authors believe that they
have an interesting and flexible integrated system of
modest size that will have an enormous impact on their
laboratory’s screening programme.
An integrated laboratory automation system for
quantitative high throughput screening (QHTS)
with cell-based assays
Mark E. Goldman, Timothy Walton,
Lynn J. Ransone and Carla M. Suto
Signal Pharmaceuticals, Inc., San Diego, CA, USA
During the past decade, large and small pharmaceutical
companies have migrated towards centralized high
throughput screening operations. One of the many
advantages of this approach is that libraries of screening
samples can be evaluated rapidly in multiple assays.
Combined with the use ofsophisticated data management
tools, the resulting information can be compared to
identify samples (either defined chemicals or natural
product extracts) that have selective activity and warrant
further characterization. In order to properly compare
data across assays, or develop estimates of structure-
activity relationships, it is becoming increasingly important
to quantify pharmacological responses. To this end, the
authors have optimized their robotics and data manage-
ment systems to conduct quantitative high throughput
screening (QHTS).
Compound are prepared using a BenchMate (Zymark
Corporation) modified to accept 16 x 100 mm test tubes
in the 8 x 12 format. Vials of compounds are placed in
boxes (8 x 12 format) and logged into the data base.
Using spatulas, approximately 5 mg samples are placed
in pre-tared test tubes, reweighed and then automatically
solvated (DMSO) to a concentration of 5 mg/ml. The
rack of tubes is transferred to a Packard MultiProbe and
500 lal aliquots are placed in deep-well microtitre plates.
For the inflammation and osteoporosis targets, cell lines
have been developed which are stably transfected with
luciferase reporter genes driven by promoters containing
appropriate transcription factor binding sites. Screening
is conducted using a custom Zymate robotics system
(Zymark Corporation). Each week, 2500 individual sam-
ples are tested in six assays (15 000 sample-assays/week).
This represents a six-fold increase throughput compared
to the semi-automated workstation assay. In addition, the
Zymate System uses one quarter of the personnel required
for the semi-automated assay. The quantity of data
generated by the Zymate System has exceeded the
laboratory’s ability to use Microsoft Excel spreadsheets
for data reduction and analysis. An Oracle-based client-
server data management system is used to register
compounds (synthesized at Signal as well as those
purchased from commercial sources) and to reduce/
compare data from many assays. This QHTS system has
allowed the authors to significantly increase productivity,
reduce screening personnel and accurately compare
results with greater confidence.
Development and implementation of microplate
immunoassays employing Zymark robotics
j. Patrick McCurley and Rose E. Sekulovich
Chiton Biocine, Department of Analytical Viral Immunobiology,
Emeryville, CA, USA
The authors’ group is responsible for the development
and implementation of assays to support Chiron Biocine
clinical vaccine trials. With a rapidly expanding vaccine
programme, and some projects already in phase 111 trials,
standard manual assays were not adequate for the required
throughput. Therefore several automation steps have been
implemented to facilitate the receiving, tracking, assaying,
data processing and data reporting process for multiple
samples.
Samples labeled with bar codes generated in-house are
compared with corresponding labels on the packing list.
The software program identifies discrepancies in the
shipment, assigns sample storage locations and records
relevant shipment information (date of shipment, shipper
and receiver IDs, etc.). A repgrt of storage locations can
be generated by entering the sample IDs manually or
from a file. Assays on selected samples are then run in a
fully automated system. A Zymark PyTechnology system
has been adapted to perform microplate immunoassays,
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and two robots are used full time to run eight different
ELISA format assays.
The data processing software matches the sample ID to
the data, generates a graphical analysis and analyses the
results obtained for the standards, controls and samples
to determine if the acceptance criteria have been satisfied.
Preliminary results are stored in a table for review by the
technician; after the review, results are electronically
transferred to a final database for reporting.
Finally, the authors are evaluating the feasibility of
adapting a Zymark .robot for microplate-based virus
neutralization assays, to increase throughput and repro-
ducibility relative to conventional plaque assays.
MANAGING LABORATORY AUTOMATION
Managing a high throughput screening group
within an international organization
Carol Ann Homon
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
During the last decade, the pharmaceutical industry has
developed high throughput screening (GTS) into a major
tool for the discovery of such drugs as Paclitaxel
(TAXOL
(R) product), and Tacrolimus (FK506). At
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), the
HTS programme identified compounds which resulted in
the discovery and development of nevirapine and ontazo-
last. The probability of finding new structural leads
increases with the number ofcompounds screened. Hence,
successful screening requires a high throughput of com-
pounds. HTS within an international company must be
organized on a world-wide basis. BIPI is part of the
Boehringer Ingelheim companies, a large international
pharmaceutical firm. Recently, Boehringer Ingelheim has
organized three dispensary units at Ridgefield, USA;
Ingelheim, Germany; and Biberach, Germany. The entire
Boehringer Ingelheim library is available for the HTS
programme through these three dispensaries. Additionally,
natural products and peptide libraries are also screened,
as are compounds obtained from outside sources. Screening
centres for Boehringer Ingelheim have been established
in Ridgefield, USA, Biberach, Germany, and Vienna,
Austria. The activities of the dispensaries and the
screening centres are co-ordinated by an international
group within Boehringer Ingelheim. This is responsible
for all logistical and technical aspects of the HTS
programme.
Managing automation for high throughput screening
Derek J. Hook
Bristol-Myers Squibb, Biomolecular Screening, Wallingford, CT,
USA
Over the last decade the pressure on new drug discovery
in the pharmaceutical industry has placed increased
emphasis on high throughput screening of chemical
compound libraries, fermentation extracts, plant samples
and now combinatorial libraries as a source of new
chemotypes for novel targets.
In order to accomplish this goal, automation has become
pivotal in achieving the necessary productivity in labor-
atories to meet challenges. The key factors critical to
implementing automation in pharmaceutical laboratories
are closely related to those elements for analytical
laboratories. There are, however, special needs for
screening, and the growth of recent symposia and courses
on high throughput drug discovery show how important
automation is to large pharmaceutical houses and smaller
biotechnology companies.
The experience of the pharmaceutical industry in man-
aging the introduction of this automation shows that there
are common factors that have been experienced by many
companies. Novel technologies are driving the emergence
ofnew types ofinstrumentation in the vendor laboratories
and show some of the possible directions that might be
taken by research laboratories in the pharmaceutical
industry. These directions will continue to put strain on
older automation concepts and they will continue to
challenge the boundaries of robotics and automation
capability.
Enabling biotechnology research using laboratory
automation
Steven D. Hamilton, Jason W. Armstrong,
Richard A. Stanton and James V. Petersen
Amgen Inc., Thousand Oaks, CA, USA
For many years, analytical laboratories have realized
increased productivity through the use of laboratory
automation. Similar technology is now becoming an
important tool to enable biotechnology and pharma-
ceutical discovery research to progress more quickly
and efficiently. More importantly, automation enables
researchers to develop discovery processes that go well
beyond the human capability to manipulate, track and
analyse.
Automation in the research environment involves such
technologies as robotics, automatic identification, machine
vision, informatics, and image and signal processing. User
friendly, robust and flexible automation must be developed
and/or applied in an environment where project speed is
critical and research directions change rapidly. These
needs have led to the creation of the Amgen Research
Automation Technologies group, whose focus is to span
the boundary between automation development and
research biology and chemistry.
The motivations, problems, rewards and strategy related
to implementing automation within a biotechnology
research organization were discussed, using examples of
the Amgen automation programme including: automated
colony imaging and picking; high density spotting,
analysis and re-arraying; automatic identification (bar
coding) and tracking; high throughput PCR preparation
and thermal cycling; automated plasmid preparations;
and high throughput compound screening.
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CHEMICAL ANALYSIS
The role of a sample preparation robotics system
at a corporate analytical research and development
laboratory
Matthew Benning
International Specialty Products, Inc., Wayne, NJ, USA
International Specialty Products (ISP) is a manufacturer
of high performance specialty chemicals. The products
have diverse applications as ingredients or processing aids
in personal care, pharmaceuticals, agricultural and
beverage formulations. The diversity of product appli-
cations is equally matched by their chemical morpho-
logical characteristics. Products are available as insoluble
powders, soluble powders, highly viscous liquids, and
non-viscous liquids.
The ISP HPLC method development group is responsible
for methods development and validation in support of
research, marketing, quality assurance, and manu-
facturing. The corporate effort on continuous product
improvement has placed demands on ISP’s laboratory
that challenge current manpower capability. Routine
analysis in support of research projects and product lines
prior to HPLC method implementation and validation
at manufacturing facilities, are a significant portion of the
laboratory’s workload.
An application has been developed to allow robotic
sample preparation for a variety ofproducts, matrices and
procedures thus freeing the chemists to pursue HPLC
method development related activities including instru-
ment setup and data processing. A Zymate II robot with
a System V controller was assembled from standard
pysections. Subsequently, hardware and software modi-
fications were implemented and validated to enable the
system to fit into our highly automated laboratory.
The uniqueness of the robotic system described is in the
software design that allows a variety of samples and tasks
to be performed by users with different sample preparation
requirements. The success of the system is measured by
the increased routine workload handled by a small group
with increased productivity. Finally, the robotics system
is one part of an automated laboratory. Integration as
evidenced by data portability, integrity, and some
regulatory concerns is easily met and enhanced with this
implementation.
(3) Weigh liquid and solid samples in amounts of
100-500 mg into different target vessels.
(4) Use different tecnniques for weighing in solid samples.
(5) Transfer the weight data to a LIMS.
(6) Label the target vessels with barcode and letters by
using an ink jet technique.
The main challenges proved to be handling of a large
variety of sample vessels, finding adequate and robust
techniques for weighing solids of varying consistency
in small amounts, and integrating the robot system
into an existing on-line data collection system and a
LIMS.
Automating the vapour test method for evaluating
chemical protective fabrics
Raymond E. Andreotti, Cyrus Kendrick, and Donald
Rivin
U.S. Army Natick Research, Development and Engineering Center,
Natick, MA, USA
An automated vapour test method that provides a rapid
and safe means of evaluating the adsorptive capacity of
fabrics used in chemical protective garments has been
developed utilizing laboratory robotics in conjunction
with an automated effluent detector. Sequential vapour
challenge analysis of fabric samples can be performed in
a pneumatically operated computer-controlled test cell
that was designed and developed not only to facilitate the
sample loading and unloading procedure, but also to
provide a test environment for obtaining precise and
reliable adsorption kinetics. A laboratory robot was
programmed to replace the repetitious and tedious tasks
formerly performed manually in the vapour test. A
personal computer is interfaced to the system and is used
for programming and control of the robotics as well as
collecting, calculating, and storing effluent concentration
test data output from the automated detector. Operational
programs were developed that can easily be updated, to
accommodate changing protocols, such as varying chem-
ical concentrations, flow velocities, temperature, and
exposure times. Use of this type of technology for
defence- and environment-related applications would
ensure that safe and reliable testing could be conducted
in governmental and industrial settings.
Automated procedures for weighing small amounts
of samples
H. Speck, M. Kranz, M. Luebke, W. Schmid and
E. Sametschek
BASF AG, Ludwigshafen, Germany
Sample preparation for ICP-spectrometry consists of two
steps: weighing and disclosure. To automate the first step,
the authors designed a laboratory robot (in co-operation
with Zymark), which can do the following tasks:
(1) Identify samples by reading barcode and getting
information on the samples from a LIMS.
(2) Open and close different capped (crimp caps, screw
caps, snap caps) and different size sample vessels.
A complete custom automation of a commercial
analytical instrument with a Zymate (R) PyTechnol-
ogy
TM laboratory robot system and the associated
computer interface
Mitchell E. Meyer, Collin B. Hitchcock, H. Robert
Pinnick, Jr. and Gordon R. Stallings
Phillips Petroleum Company, Research & Development, Bartles-
ville, OK, USA
The challenge of completely automating an analytical
technique is often related to the interface between the
robot, the analytical instrument instrument, a Laboratory
Information Management System (LIMS), and the
associated sharing of data between these systems. This
paper discussed an approach employed on three Applied
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Research Laboratories (ARL) Inductively Coupled
Plasmas (ICPs) to fully automate these analytical
instruments utilizing a customized Zymate
(R) PyTechnol-
ogy
TM system, a desktop computer (PC), a LIMS system,
and a local area network (LAN). This design can be used
for future robotization and automation efforts with other
commercially available instrumentation.
Combining robotics with UV-VIS-NIR spectroscopy
Carl G. Zimba
Polaroid Corporation, Cambridge, MA, USA
In the development of new photographic media it is
necessary to evaluate the colorimetry of a large number
9g dyes and other components. As these prototype
materials are synthesized, the absorption ofthese materials
in the ultraviolet, visible, and near-infrared spectral
regions are measured to verify both their absorbance
maxima and their absorption intensity.
As part ofan ongoing effort to automate routine analytical
spectroscopic measurements, a laboratory robot has been
combined with both a UV-VIS and VIS-NIR spectro-
photometer. The result has been the creation of a highly
automated instrument which prepares solutions from
powder or crystalline samples using a variety of solvents,
and measures the absorption spectrum.
Using this instrument, sample characterizations can be
accomplished with more rapid turn-around, more precision
and accuracy, and in some cases with less material.
Furthermore, the available staff can be better utilized to
meet the needs of Polaroid’s analysis clients.
The presentation gave an overview of both the hardware
and the software of this automated spectrometer and
compared the performance of this instrument to manual
methods. Potential applications to a more traditional
QA/QC environment were also discussed.
Automation of a NMR measurement of finish-on-
fibre
James Rodgers and Joel Weekley
Fibers Division of Monsanto, Gonzalez, FL, USA
Finish is applied to the fibre surface primarily to assist
the fibre’s performance during downstream processing.
The quantity of finish applied to the fibre surface is called
Finish-On-Fibre (FOF). FOF is an important process and
quality control parameter for textile fibres and yarns, and
it has historically been measured by solvent extraction
techniques. A Nuclear Magnetic Resonance (NMR)
method, using the bench-top Oxford QP20 pulsed NMR
analyser, was developed for the measurement ofFOF on
nylon fibre products (carpet, tire, conductive fibre). The
NMR instrumentation yielded rapid, cost effective,
accurate, and precise non-destructive measurements of
FOF. Since the NMR analysis requires no solvents,
significant environmental and cost-related benefits were
realized. Excellent FOF agreement was obtained between
the NMR method and a standard solvent extraction
technique. A program was initiated to interface the NMR
unit to a laboratory automation system. Several auto-
mation vendors were compared using a Comparison
Matrix (technical capabilities, partnership potential,
economics). A Zymark Zymate XP system was determined
to be the optimum laboratory automation system for this
application. A joint Monsanto-Oxford-Zymark program
was established to implement hardware and software
integration of the Zymate XP system to the Oxford NMR
unit and to Monsanto’s QC and LIMS systems. Custom-
ized Oxford-Zymark software allowed control oftheNMR
and robotic functions by the System V controller.
Customized Monsanto-Zymark software resulted in the
successful integration of the NMR results into the Plant
LIMS system.
Adsorbable organic halogen compounds (AOX):
robot-based automated analysis
Helmut Dillenburg and Bernhard Koerner
Solvay Alkali GmbH, Rheinberg, Germany
The parameter AOX (DIN 38409 T14 Adsorbable
Organic Halogen Compounds, where X C1, Br, J) is,
due to legal regulations and prescriptions, one of the most
’popular’ analytical parameters in Germany, if not in
Western Europe, for the analysis ofwater and wastewater.
But it is also very time-consuming and therefore costly.
A well-trained laboratory operator can analyse about 8
to 10 samples (double estimation) per shift. Thus a lot of
attempts have been made to automate all of the analytical
procedure or at least major parts of it.
The principle of measurement is as follows: the organic
components of the sample are adsorbed on active carbon.
Interferences ofinorganic halogen compounds are removed
by rinsing the adsorption-columns with an aqueous
solution of sodium nitrate. The loaded active carbon is
then combusted in an oxygen stream. The generated HX
are absorbed and the mass of halogen is detected.
This paper described a fully automated, Zymate-robot-
based, DIN-compatible procedure, comprising sample
identification, enrichment step, sample transfer and
interfacing to a commercially available automated
analysis system, data collection, evaluation and docu-
mentation of the results. Starting with the validation
process, results for calibration standards and real-life
samples are compared with the results obtained by the
manual DIN-procedure in parallel. The comparison
showed excellent consistency. The sample capacity of the
system is 10 samples per shift (triple estimation and
calibration) and can be easily adapted to specific needs.
DRUGS IN BIOFLUIDS
An evaluation of automated solid-phase extraction
systems
R. Eric Schmidt, L. A. Kosobud, N. S. Khoshaba,
and K. J. Miller
G.D. Searle & Company, Skokie, IL, USA
An evaluation ofcommercially available automated solid-
phase extraction (SPE) systems to perform the extraction
of pharmaceuticals from plasma and urine samples was
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conducted. The evaluation focused on increased through-
put and the creation of automated assays which could be
transferred to contract laboratories for routine analyses.
The Gilson ASPEC XLTM, Hamilton MicroLab 2200TM,
Zymark BenchMateTM, Zymark RapidTraceTM, and the
Cardinal AutoChem WorkstationTM, were evaluated.
The evaluation focused on three components: (1) hard-
ware, (2) software/programming, and (3) application
of an established assay presently using a Zymark
PyTechnology robot. For the hardware and software/
programming, the advantages and the disadvantages of
each system were generated. For the application, the
analysis time, carry-over, precision and accuracy were
compared and conclusions were drawn regarding system
applicability for automated sample preparation.
Use of a Zymate system for bioanalytical auto-
mation as a workstation
Michael Wirth, Mats Svensson and
Torbjorn Arvidsson
Pharmaceutical and Analytical R&D, Analytical Chemistry,
Astra Pain Control AB, 151 85 Sodertalje, Sweden
Robotics in bioanalytical work often comprises fully
automated systems developed for a given method. This
paper introduced a concept based on automation of the
bioanalytical work using different types of general
workstations. Several such stations are commercially
available--dilutors, solid-phase extraction systems, auto-
injectors etc.
A new type of workstation using a Zymate robotic system
has been developed for the necessary steps following
extraction (evaporation, reconstitution and transfer to
autosampler vials including capsulation). The develop-
ment, test and validation of the robotic system was
discussed. The concept has been applied in a bioanalytical
method for determination of local anaesthetic drugs in
blood plasma using liquid-liquid extraction and gas
chromatography.
Flexible automation tools for drug metabolism
Thomas L. Lloyd and Michael G. Dodds
Drug Metabolism Department, Glaxo Wellcome, Research
Triangle Park, NC, USA
Robotics was first introduced into most drug metabolism
laboratories as a means to automate routine assays.
Existing methods for biological fluid sample analysis were
transferred to an automated platform to support large
clinical studies. Systems were often dedicated to one
application and the decision for automating a project
hinged on whether the workload for that project justified
the investment in equipment and set-up time.
As the flexibility and variety ofautomation tools progressed,
the range of application extended upstream in the drug
metabolism process. Robotic systems are still used to
automate analysis for large clinical studies. However, they
are also used for smaller volume pre-clinical and research
support applications. The automated systems are flexible
enough to handle up to six different assays in a week and
multiple compounds within an analytical run. Bio-
analytical methods are developed and refined directly on
an automated platform in conjunction with experimental
design software. By minimizing or eliminating set-up time
between applications, a steady supply of low volume
bioanalytical applications can also be cost effective.
The breadth of automation for these applications has
expanded as well. Bioanalytical sample preparation tech-
niques include solid phase extraction, liquid-liquid
extraction, protein precipitation and dialysis. Sample
container labels can be generated and applied auto-
matically for a variety of different container dimensions.
Standards and quality controls can be prepared from a
concentrated stock and stored in the same labeled
containers. A number of sample preparation processing
options are available. Prepared samples can be analysed
on-line or stored in autosampler vials. Automation
continues to be developed for new diversified applications
within drug metabolism.
Extraction of morphine and codeine from urine
samples using the Zymark RapidTrace
Francis X. Diamond, William H. Vickery and John
de Kanel
National Medical Services, Inc., Willow Grove, PA, USA
Morphine and codeine are the two opiate drugs designated
by SAMHSA (Substance Abuse Mental Health Service
Administration, formerly the National Institute for Drug
Abuse, NIDA) for analysis in employment and pre-
employment situations to determine if heroin, codeine or
morphine have been used. Numerous methods have been
published describing methods to extract morphine and
codeine from urine either by traditional liquid/liquid
means or by solid phase extraction. Liquid/liquid
extractions are time consuming, difficult to automate and
require great analyst skill if they are to produce repro-
ducible and accurate results. Each manufacturer of solid
phase extraction cartridges has published methods to
accomplish the extraction of morphine and codeine from
urine. For the purposes of evaluating the Zymark
RapidTrace
TM automated extraction workstation the
authors chosen 3 ml Confirm HCX IsoluteTM cartridges
which are available in the USA from Jones Chroma-
tography, Inc. The method was programmed into the
RapidTrace
TM software without modification. A set of 10
Zymark RapidTrace sample preparation units controlled
by one personal computer was capable of extracting
codeine and/or morphine from 50 urine samples per hour.
The samples were then evaporated to dryness at 40C
using a Zymark TurboVap. This step took approximately
10 minutes. The samples were then derivatized by reaction
with 50 gl (BSTFA with 19/o TMCS) in 501 gl ethyl
acetate for 30 minutes at 70C in a sealed tube. The
samples were then transferred to autosampler vials and
analysed by GC/MS. A technician would previously have
spent at least three hours to prepare these extracts
manually--the use of the RapidTrace frees the technician
to work on more productive things such as data review
for two of the three hours.
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Two millilitre urine samples known to be negative for
codeine and morphine were spiked with deuterated
codeine and morphine at levels of 50 ng/ml as internal
standards and with codeine and morphine at varying
levels to evaluate the recovery, linearity and carry-over of
the extraction method when performed by the Zymark
RapidTrace. The results for codeine and morphine are
shown in tables and 2. The standards at 150, 300, 600,
1200 and 2400 ng/ml were used to determine back
calculated levels for these standards and to quantitate
the controls at 240 and 360 ng/ml, as well as levels in
various blank samples. Urine samples were extracted
through the procedure after spiking it with 50 000 ng/ml
of morphine or 1000.00 ng/ml codeine. Analysis of the
blank samples following these spiked samples was done to
estimate carry-over. The procedure used was identical to
the routine procedure which would be followed for real
samples. No extra manipulative steps were added in an
effort to minimize carry-over. The extracts from the
50 000 ng/ml or 100 000 ng/ml samples were not deriv-
atized nor analysed by GC/MS since potential carry-over
from the GC autosampler could have confused the results.
Under SAMHSA guidelines, an affirmative cut-off of
300 ng/ml is used to administratively differentiate positive
samples from negative ones. Irrespective of other data,
samples containing codeine or morphine below this
administrative level are reported to clients as negative.
Direct quantitation of the blanks following the 100000
ng/ml codeine spike yields 65 ng/ml or 0"07% carry-over.
Table 1. Codeine analysis: Diamond et al.
Calculate Ion Ion Ion
Spike D ratio ratio ratio
ng/ml level, ng/ml 229/371 356/371 229/356
150 160 0"32 0"13 2"5
300 340 0"37 0"12 3"1
600 640 0"45 0’ 13 3’5
1200 1100 0"59 0’ 14 4"2
240 control 220 0"38 0’ 13 2"9
360 control 320 0"40 0’ 12 3"3
0 0"56 2"8 1"6 1"8
0* 65 0"39 0’15 2"6
* Blank extracted after the 100 000 ng/ml spiked sample extraction.
Table 2. Morphine analysis: Diamond et al.
Calculate Ion Ion Ion
Spike D ratio ratio ratio
ng/ml level, ng/ml 401/429 414/429 401/414
150 150 0"28 0"43 0"65
300 330 0"30 0"46 0"65
600 560 0"29 0"45 0"64
1200 900 0"31 0"47 0"66
240 control 210 0"32 0"53 0"60
360 control 330 0"33 0"47 0"70
0 1"1 0"51 2"3 0"22
0* 16 0"34 0"54 0"63
* Blank extracted after the 50 000 ng/ml spiked sample extraction.
For morphine, the blank following the extraction of the
50 000 ng/ml spike yielded 16 ng/ml or 0"03% carry-over.
Some of this level is derived from the background noise.
The blanks extracted after relatively low levels of
benzoylecgonine quantitate to approximately ng/ml, for
example. These levels are all far below the administrative
cut off of 300 ng/ml.
Fully automatic determination of the enantiomers
of amlodipine in human plasma by robotic sample
preparation and gas chromatography
K. D. Riedel, F. Scharpf, H. Laufen and M. Leitold
Department of Pharmacology, Pfizer Mack, Illertissen, Germany
A sensitive and specific gas chromatographic (GC)
method using a Zymark II robotic system for complete
sample preparation was developed for the determination
in plasma of the enantiomers of amlodipine, a calcium
channel blocking therapeutic agent. Plasma samples were
alkalinized and extracted with tert.-butyl methyl ether
(TBME). Amlodipine and the internal standard (a C1
analogue of amlodipine) were then back extracted into
citric acid. After discarding the organic layer the aqueous
layer was alkalinized and again extracted with TBME.
The ether phase was then evaporated to dryness under a
stream of nitrogen. For chiral derivatization the dried
extracts were reconstituted into a solution of (+)-(S)--
methoxy--trifluoromethylphenylacety chloride. After
removing the excess reagent with potassium carbonate the
diastereoisomers were then analysed by GC with electron
capture detection.
The limit ofdetection of this method is 0"02 ng/ml plasma
for both enantiomers. The day-to-day %CV ranged from
2"6 to 11"7 (both enantiomers). The corresponding within
day %CV ranged from 2"6 to 11"7. The Zymate system
performs the complete extraction, back extraction,
evaporation, derivatization and transfer of the extracts
into autosampler vials for gas chromatography. The
system consists of the following components (number of
modules in brackets): dual-function hand (2), liquid-
transfer hand (1), power and event controller (2), rotating
overhead shaker (1), centrifuge (1), evaporator (1), screw
capper (1), crimp capper (1), vortex mixer (1), dispensing
station (2), pneumatic dosing station (1), as well as various
sample racks.
A total of 50 samples can be automatically prepared by
the robot within 30 hours. This corresponds to a total
sample throughput ofabout one sample per 35 min, which
is similar to the chromatographic time.
PHARMACEUTICAL ANALYSIS
Analysis ofwater soluble vitamins in multivitamin-
mineral supplements on an automated tablet
processing-liquid chromatographic system
Andrew L. Deputy and Lionel P. Murray
Bayer Corporation, Consumer Care Division, Elkhart, IN, USA
This presentation described a project to develop a rugged
and reliable automated analysis system for ascorbic acid,
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folic acid, niacinamide, panthothenic acid, pyridoxine,
riboflavin and thiamine in multivitamin-mineral supple-
ments. In addition, the analytical system must be robust
enough to process a large number ofsamples with varying
formulations and physical characteristics. These differ-
ences in products can include colour, flavour, coating,
tablet shape, tablet hardness, types and amounts of active
ingredients, and multiple tablet excipients.
In order to produce such an automated system, a
chromatographic separation was developed which is
extremely rugged and insensitive to minor changes in the
tablet excipients, including the flavours and colours.
During the development of such a rugged separation, the
chromatographic separation was optimized for capacity
factor (k’) and selectivity (). Because of the interrelated
nature of these two parameters, an ’expert’ approach was
used for the development of the HPLC separation. In
addition, post-column derivatization was employed for
those vitamins which either do not have an easily
accessible chromophore or whose chromatographic be-
haviour does not yield the desired selectivity over
interfering components of the table matrix. For the
multivitamin-mineral supplements, ascorbic acid and
pantothenic acid meet these criteria.
The optimization of the aqueous extraction of the water
soluble vitamins was accomplished using a Taguchi
Methods(R) Optimization scheme (Lg) to examine the
influence of various parameters on the extraction of the
vitamins from the tablet matrix. Extraction parameters
examined included homogenization time, extraction
temperature, extraction solvent pH, and pre-extraction
soak time. Parameter conditions and ranges were selected
to optimize the precision (S/N) of the extraction process;
therefore, providing a rugged automated anlaysis system.
In summary, a rugged, precise analysis system is necessary
for use in the routine release testing of pharmaceutical
products. By the use of experimental design techniques,
it is possible to build ruggedness into the analytical system
during development.
The BenchMate II TPWmfrom installation to
financial success
Simon Smith
SmithKline Beecham Pharmaceuticals, Manor Royal, Crawley,
West Sussex, UK
The Quality Assurance Department at SmithKline
Beecham performs the testing of samples for stability,
process development/new product introduction and
routine release for sale. As a consequence of long-term
management objectives, the goals are to reduce laboratory
testing time to 24 hours and eliminate waste while
maintaining or reducing costs. Within the analytical
laboratory, automation can provide the key to these
business challenges. Ifcareful implementation is employed,
the automated laboratory will emerge as the successful,
cost effective and efficient laboratory of the future. This
result will consequently give that certain leading edge to
any product in the aggressive market place and allow
greater flexibility as the automated laboratory will be
situated at the end of the production line.
The release for sale and stability testing of a particular
film coated tablet has been automated within the
laboratory by the successful implementation of a Bench-
Mate II Tablet Processing Workstation. Initial justification
for the purchase of the system was based on the view that
it would replace an analyst and create extra capacity.
This view has been realized but many hidden benefits
have emerged, with the main ones being a reduction in
inventory costs and the number of samples requiring
retesting.
Due to the success of this first automation challenge, a
second system was purchased, validated and implemented
in a third of the time of the first system and is now also
used for the testing of a second product.
Robotic-LC analysis of Benadryl tablets
Fern Smith and Harold Shaw
Parke-Davis/Warner Lambert Company, Brockville, Ontario,
Canada
The BenchMate TPW Workstation (Zymark Corporation,
Hopkinton) consists of two parts, the BenchMate Work-
station and the Tablet Processing Workstation. The
BenchMate TPW Workstation provides a versatile, cost
effective alternative to manual sample preparation for
content uniformity assays, potency (composite) assays,
and dissolution testing. These routine tests require samples
to be ground, dissolved, filtered, diluted, and analysed by
chromatographic techniques. The BenchMate TPW
Workstation utilizes computer controlled wet-grinding
homogenization, a liquid management system, an internal
four place analytical balance, and a three place top
loading balance to consistently provide accurate and
precise results. The workstation also provides an audit
trail for all sample weights used and sample volumes
transferred.
Fast dissolution sampling and analysis using a
Zymark dissolution robot and on-line UV/visible
spectroscopy
Daniel W. Barrow
Bristol-Myers Squibb, New Brunswick, NJ, USA
Dissolution testing is a common analytical procedure used
throughout the pharmaceutical industry to meet legal
requirements for compendial drugs and to provide a
quality control measure for solid dose forms in manu-
facturing and research operations. Fast on-line UV/visible
dissolution sampling and analysis have been achieved
using a customized Zymark dissolution robotic system.
The system is capable ofsampling and analysing solutions
from a single vessel in less than 50 seconds: allowing six
vessels to be tested in under five minutes. It is equipped
with a second six vessel dissolution tester thus enabling
analysis of 12 dissolution samples in under 10 minutes.
The dissolution procedure is fully automated including
analytical standard analysis, system preparation, sample
addition and analysis, system clean-up, results calculation
and print-out. Common productivity gains range from
50 when compared to conventional robotic dissolution
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systems to 300 when compared to manual methods of
analysis.
This robotic system has been used in the analysis ofseveral.
pharmaceutical products. The presentation showed
system schematics and system validation data.
Using a PyRobotic system to update and automate
the existing analytical methodology in a currently
marketed product
cation. Instead of programming for specific applications,
an expert program interacts with the user to create the
application program. The installation qualification and
operational qualification protocols were used to demon-
strate that the robotic system hardware and expert
program are working as intended. The performance
protocols were used to validate the application programs
generated by the expert program and to demonstrate
equivalence to either manual or other automated pro-
cedures.
Allan L. Greenberg and Phillip A. Lane
Analytical Research and Development, The R.W. Johnson
Pharmaceutical Research Institute, Raritan, NJ, USA
Laboratory robotics have been previously demonstrated
to be most efficiently used where conditions make repro-
ducibility important and sample throughput prime
considerations. Most of the previous implementations in
the authors’ laboratories have been in the application of
robotics to new dosage form sample preparation schemes.
However, in the pharmaceutical industry, especially in
today’s climate of having to work faster and more
productively, it is easy to go backwards and implement
automation into pre-existing analytical procedures rather
than only considering application of robotics to new
chemical entities.
The robotics programs used were taken from a cream
application, which was presented two years ago at ISLAR.
A comparison ofthe flow diagrams ofthe original program
and the desired program was used in the presentation to
indicate what part of the program could possibly be
salvaged. The programs were modified to meet current
analytical requirements. The new robotic procedures also
incorporated a system suitability check and preparation
of standards.
The results from the assay of robotically prepared cream
samples were compared to manually prepared samples.
The evaluation concluded that the results were statistically
equivalent. The assay reproducibility and sample through-
put was presented for both cases.
Using an expert system with laboratory robots to
provide flexibility in the analytical development
laboratory
M. E. Hinshaw and D. A. Jackson
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis,
IN, USA
Until recently, robots have been of limited use in the
authors’ pharmaceutical development laboratories. The
time required to plan, build, and validate systems is not
well accommodated in today’s accelerated development
environment and once the bolus ofsamples is through the
system, the robots are generally not flexible enough to be
used for other projects without substantial modification.
This problem has been addressed by changing the basic
approach to building robotic systems at Eli Lilly. Each
system is now constructed to allow for multiple sample
preparation techniques using various container sizes,
regardless of the requirements of the immediate appli-
Installation, validation, and implementation of the
Zymark MultiDose Automated Dissolution Work-
station for profile testing oftablets using the paddle
apparatus
John J. Mullen and Timothy J. McCormick
The DuPont Merck Pharmaceutical Company, Wilmington, DE,
USA
The MultiDose Automated Dissolution Workstation
automates the paddle method for dissolution testing of
pharmaceutical solid dosage forms. With minimal operator
set-up the system will automatically dispense dissolution
media, check the temperature, introduce tablets, and
provide selected profile sampling at intervals as close as
five minutes. The installation process supplied by the
manufacturer helped provide for a problem-free start up.
Zymark engineers were able to set-up and have the system
operating in several days.
A thorough system hardware and software validation was
conducted which included the IQ, OO and PQ of the
system. The Installation Qualification confirmed that the
analytical balance, thermisters, pumps, and all other
components were installed correctly and that they
operated as expected. The Operation Qualification
verified the functional and applicational performance of
the workstation. All components did operate as they were
intended throughout anticipated ranges. The Performance
Qualification of the system was the actual execution of
an analytical procedure without an error and in the
correct sequence.
Product/application specific validation was also conducted
which included: calibration, sample solution carry-over
checks, vessel washing effectiveness and manual versus
automated comparisons.
The results of the above installation/validation process
were presented along with the implementation of the
system for product stability testing.
Automated dissolution testing in the validation of
tablet coating procedures
Kevin K. Olsen
ESI Lederle Generics, Pearl River, NY, USA
A common medication is manufactured in four strengths
by ESI Lederle Generics at their Pearl River New York
facility. Validating a recent change in the tablet coating
operation required extensive dissolution testing in which
the tablets are allowed to dissolve under tightly controlled
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conditions and the concentration of the active ingredient
is measured as a function of time. Such testing is very
commonly used to monitor the release characteristics of
a wide variety of pharmaceutical preparations.
Since two separate pieces of coating machinery were
involved, almost all the analyses were done twice. Each
of the four tablet strengths required testing on uncoated
tablets, dissolution profiles, and testing of tablets taken
from different steps in the coating process. The estimated
time to complete the testing by manual methods was over
300 hours. In addition, the laboratory had to support its
normal workload of quality control analyses.
Substantial savings of time were achieved by automating
the testing procedures using a Zymark MultiDose, an
autosampler on the UV/Vis spectrophotometer and a
Beckman LIMS to manage data handling and routine
calculations. The Zymark MultiDose was the critical
element because it allowed the entire test to be automated,
including the very labour intensive steps of cleaning the
apparatus and preparing it for the next sample. The final
result was a documented saving of slightly more than
50 in analyst time. Results obtained by the automated
system were in good agreement with those from manually
prepared samples.
DATA HANDLING
Automation of data handling for trace analysis of
drug active in on-line cleaning validation samples
Jon P. Sadowitz and Thomas D. Groeschner
Schein Pharmaceutical Inc., Carmel, NY, USA
In response to current concerns a cleaning validation
program was developed. Within this program, it became
necessary to automate the analysis of data to increase
productivity within a small group solely responsible for
the analysis of all cleaning validation samples. Until very
recently, data analyses were performed by hand, which
consumed much of the analyst’s time when dealing with
the large number of samples associated with a cleaning
validation study: a small cleaning validation study of 50
tubes would require over 150 individual calculations. For
a small staff of two chemists, automated analysis was
essential.
This presentation included the development and overview
of the final product utilized in the automated transfer of
raw chromatographic data to transform these data into
a workable tbrmat to interpret the results of a cleaning
validation study.
LABORATORY WORKSTATIONS
Automating the process of removing coating ma-
terials from tablet formulations
Kathy Duquette
Wyeth-Ayerst, Rouses Point, NY, USA
and Chris Werner
Bohdan Automation, Mundelein, IL, USA
This presentation demonstrated an automated system that
is capable of removing the coating material from the
active inner core of pharmaceutical tablet formulations.
In addition to selectively removing the coating material,
the instrument also calculates and records the average
tablet core weight..
The initial intention of the automated workstation was to
free the analyst from the time-consuming task of washing
the tablets by hand. The analyst is now able to wash up
to 12 batches of coated tablets with a very short amount
of time needed to set up the machine. In addition to
improving the use ofvaluable employees, more consistent
results are achieved using the automated approach.
The tablet washer has the capability of washing, rinsing
and drying the tablets. A variety of’run parameters’ are
addressed by the analyst at the beginning of the program.
The computer program also stores the weights of the
tablets in its memory, as well as a hard copy print-out.
This allows the laboratory to have both permanent and
electronic documentation of the sample preparation and
sample data report.
To date, the automated workstation has shown results
that are equal to or better than manually prepared
samples.
Automation of a tablet assay using a BenchMate
TPW
Michele E. Lake, David A. Hollowell,
James L. Sabatowski and Mark N. Flair
Eli Lilly and Company, Lilly Research Laboratories, Indianapolis,
IN, USA
A Zymark BenchMate Tablet Processing Workstation
(TPW) has been used to successfully automate a potency
determination for tablets resulting in precise results and
substantial savings in analyst time. During automation
of the potency method, several iterations of the TPW
procedures were examined. TPW results generated with
the various procedures were compared to manual results
(as well as the percentage label claim) until both sets of
results were statistically equivalent. Since validation of
the automated method, a control sample has been utilized
and a control chart of this data has shown the reproduci-
bility of the TPW for the assay of tablets. The TPW data
has been analysed to evaluate the method variability (run
to run), as well as tablet variability for the established
control sample. This presentation described the automated
assay and the results.
Automation of the analysis of an unstable analyte
in solid dosage forms with the BenchMate TPW
L. A. Cavenaghi and E. Gabriele
Guppo Lepetit SpA, Anagni, Italy
With the use of a BenchMate TPW, the authors have
been able to automate the analysis of Rifampin in solid
dosage forms. This antibiotic, which is widely used for the
treatment of difficult infections, is formulated in sugar
coated tablets of different strength ranging from 100 to
600 mg, and up to now could not be analysed automatically
because the compound oxidizes in solution.
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The use of the BenchMate TPW with its capability of
preparing standards and samples (weigh, dissolve, dilute
and inject) at the appropriate moment has solved the
problem.
A new method has been developed to cover all those in
use for the different formulations. The method covers the
range 80 to 720 mg/sct (__20 of theoretical content),
enabling the laboratory to have an enormous increase in
flexibility of response. This increase was achieved with no
loss of precision and accuracy of the analytical procedure.
An added bonus ofthe use ofthe BenchMateTPW was the
ease of the validation with automatic tracking of all the
dilutions and thus removing the need to validate the
analyses.
Workstation automation ofthe biochemical oxygen
demand method
Lars Lindquist, Sonja Soloway and Donna Pocius
WMX Environmental Monitoring Laboratories, Inc., Geneva,
IL, USA
A fully automated BOD workstation was developed to
automate the Environmental Protection Agency method
405.1. This system has the capability to deliver sample,
seed, controls, and dilution water to BOD bottles. The
dissolved oxygen is measured with a probe and a water
seal is formed when the cap is placed on the BOD bottles.
The operation of the Zymark workstation with a personal
computer running WindowsTM is very user friendly
because it uses Visual Basic images of the samples, racks,
and BOD bottles. The user points and clicks on the mouse
to screen images of the sample bottles and inputs the
information to set up the analyses. The BOD bottles that
are analysed are tracked with a bar code reader. The
results can either be reported from a standard report or
customized by use of other spreadsheet software.
System validation, method detection limits, sample
throughput, and performance characteristics were pre-
sented.
VALIDATING LABORATORY AUTOMATION
The generic dictionary: a new approach to validation
P. J. Gallant and R. S. White
DuPont Merck Pharmaceuticals, Radiopharmaceuticals Division,
Process Testing Development, Billerica, MA, USA
In most GLP/GMP environments, the major downtime
to implementing automated systems is the validation
process. With respect to the Zymark XP system in DMPC’s
Process Testing Group, the major drawback to converting
the current XP system over to new analyses is validating
the new configuration on a relatively unchanged system.
The concept of a generic dictionary places emphasis on
the range of functionality versus function for a given
application/use. Consider a liquid/liquid transfer station,
currently validated and used to aspirate/dispense 2 ml. A
generic version of this application would be validated for
aspirating/dispensing operations with volumes ranging
from 0"5 to 10 ml, as opposed to the fixed volume of 2 ml.
When a new sample process is required, any volume
between 0"5 and 10 ml could be implemented without
revalidating the functioning of the liquid/liquid transfer
station.
On a broader scale, the entire dictionary can be designed
with this generic focus. The various functions the XP
system performs can be broken down into functional units.
Functional units are similar to laboratory operation units
(LUO), although the emphasis for functional units is on
the range of functionality for a given operation versus
repetition of that operation.
This presentation outlined the concepts and the authors’
experiences in implementing the generic dictionary on an
existing XP system.
Systematic approach to automation validation
W. J. Ewing and P. J. Gallant
DuPont Merck Pharmaceutical Company, Radiopharmaceuticals
Division, Billerica, MA, USA
The trend in today’s laboratories is movement toward
automation. This advancement is accompanied by the
need to validate the automated system. This process can
be very long and time-consuming; however, with the
proper knowledge and planning, the validation process
can be short, painless and very successful. Initially, the
idea about an automation project is conceived, and then
the research and investigation begins to find the perfect
system and design to suit specific needs. A rough layout
or system plan should be generated to ensure that the
system obtained can perform to the expectations. The
functional requirements document should be written in
which the system will be described in general and the
operational requirements of the system will be stated. A
system specification document is also required which is
made up of hardware and software design specification
of the system.
A validation plan needs to be established that will include
the documentation necessary to prove that the system
performs its functions properly and is consistent with the
functional requirements and system specifications. The
validation plan also identifies all the required tasks and
responsibilities needed to have a successful validated
system.
The actual validation testing can be broken into three
parts: installation qualification; operational qualification;
and performance qualification. The installation qualifi-
cation (IQ) test is performed to ensure that all of the
equipment is installed according to the manufacturers’
specifications and recommendations. The operational
qualification (OQ) tests that the system components each
perform correctly within their operation ranges. The
performance qualification (PQ) provides proof that the
system performs all its functions accurately, reliably and
in accordance with the functional requirements.
This presentation described the steps involved in validating
an automated system and maintaining that system in
compliance once it has been validated.
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A generalized performance based approach to the
operation qualification of the Zymark BenchMate/
TPW
David A. Hollowell, Mark N. Flair, Jeffrey D. Hofer,
and Michele E. Lake
Eli Lilly and Company, Lilly Research Laboratories, Indianapolis,
IN, USA
A generalized approach to the operational qualification
of a Zymark BenchMate/TPW has been defined and
executed in the Pharmaceutical Analytical Development
Division at Eli Lilly and Company. The operational
qualification (OQ] .is intended to produce documented
evidence providing a high degree of assurance that the
automated system is capable of reliably performing the
desired analytical functions in the laboratory. Using
vendor specifications and statistical techniques, rational
limits for automated operations have been derived from
NIST Class A specifications for the glassware-equivalent
manual laboratory operations. This approach was under-
taken in order to be able to confidently utilize the equip-
ment for development of analytical methods as well as
to validate the automation of manual procedures. This
presentation gave the approach, results, and conclusions
of this operational qualification.
DRUG DISCOVERY RESEARCH
The automation of radioisotopic and luminescence
assays for high throughput screening
Alfred J. Kolb
Packard Instrument Company, Meriden, CT, USA
The number ofsamples being analysed in high throughput
screening has been growing at an acclerating rate over
the last five years. To keep up with this demand,
pharmaceutical companies have been drawing upon
innovations in analytical instruments, microplates, assay
technology and robotics. The core instruments in most
screening laboratories include liquid handling systems and
an array of analytical instruments such as densitometers,
luminometers and microplate counters for radioisotopic
measurements. These instruments can handle a sub-
stantial sample throughput when combined with micro-
plates and assay technologies that reduce, or eliminate,
sample processing steps.
Microplates with integral filters have eliminated the need
to handle individual filters for the analysis of receptor
binding or cell proliferation. The harvesting and analysis
ofsamples occurs in the same microplate, thereby reducing
sample preparation time. In-plate assays for immuno-
binding, receptor binding and nucleic acid hydribidization
have been designed that require only a simple aspirate
and wash step. Other assay systems completely eliminate
the need to separate bound from free label. Many of these
assays are available using radioisotopic labels or new
luminescent reagents with half-lives of hours instead of
minutes. This allows the researcher to choose from a range
of methods that best suit the individual laboratory
requirements.
The simplification or elimination of separation steps has
also simplified the complete robotics automation of
screening assays. Filtration assays for receptor binding
could not be automated when these assays required the
use offilter disks or sheets offilter paper. The development
ofmicrofiltration plates and non-separation assays offered
a practical solution for robotics automation.
The co-operation of Packard Instrument Company and
Zymark is an example of how companies can combine
their strengths to offer solutions to the automation ofhigh
throughput screening.
Automated template preparation for high through-
put sequencing with BioRobot 9600
Michael Collasius
QIAGEN GmbH, Hilden, Germany
and Alex Zrolka
QIAGEN Inc., Chatsworth, CA, USA
The BioRobot 9600 has been designed specifically for high
throughput production ofultrapure sequencing templates.
Templates can be prepared using either the QIAwell
Ultra or QIAprep M 13 Systems. The QIAGEN kits have
been optimized in our research facilities for use with the
BioRobot 9600. The BioRobot 9600 can meet the through-
put requirements of any type of laboratory. Depending
on the type, source and quantity ofDNA templates being
purified, the workstation can deliver up to 96 templates
in as little as 2 hours.
The BioRobot 9600 hardware can be easily adapted to
meet changing research requirements. The modular
platform allows the option to upgrade as necessary, or as
new technology becomes available. The workstation
combines the novel QIAGEN operating system with the
Windows user interface to provide eash set-up and
execution. The point and click operation can be used to
modify existing protocols or even create new applications.
The BioRobot 9600 provides the reliability of proven
purification chemistry with the high throughput require-
ments of modern laboratories.
An automated system for preparation of radio-
labeled antibody
Jimmy Brunet, Julie Stimmel and Doug Wilson
Glaxo Wellcome Inc., Research Triangle Park, NC, USA
A laboratory robot has been developed to perform the
radioligand labeling of clinical quantities of a monoclonal
antibody. The system was developed in response to a
problem of high radiation exposure to staff using manual
manipulations. A small Zymate XP robotic system was
assembled to perform radiolabel preparation, radioligand
binding and cleanup of the radiolabeled antibody using
a spin, size-exclusion column.
A new 0"1-10 gl Eppendorfpipette hand was implemented
optimized and characterized. The 0"1-10 gl Eppendorf
hand (fabricated by Zymark) uses the variable plunger
mechanism of a standard Zymark pipette hand. Custom
software was developed to allow variable volume dispensing
from the Eppendorf with a linear calibration adjustment
made in the software. Accuracy and precision of 5% and
41Abstracts of papers presented at the International Symposium on Laboratory Automation and Robotics
+_59/o were achieved at a lal nominal volume with
accuracy and precision of2% and 4-1% at 10 gl volume.
The radiation exposure of scientists was reduced signifi-
cantly, allowing for more frequent and safer experiments.
The robotic method improved reproducibility and overall
recovery of radiolabeled antibody versus the manual
method.
Motion control of an X-Y stage and autofocus for
a microscope using a commercially available
vision and instrument control package
Joe J. Yacobucci, Jeff Guss and Derek Hook
Bristol-Myers Squibb, Biomolecular Research, Wallingford, CT,
USA
Many biological responses are accompanied by a shape
or fluorescent change. Q.uantitating these changes by eye
using a microscope or a television monitor is tedious and
prone to error with the added difficulty of controlling for
operator-to-operator variation. The authors report on the
application ofan X-Y stage and autofocus for a microscope
using Ludl motion hardware, and software.
Topics discussed included automated X-Y stages, auto-
focussing, computer logic commands, image prameters,
and the use of a Zymark robot to facilitate unattended
operation.
This system has processed unattended over 100000
microplate wells.
steps. Once this intermediate processing is completed, the
original source container is typically returned to its
original location.
Various strategies exist for automating the storage/retrieval
and preparation processes. Approaches include attempting
to automate the complete procedure to selectively
automating steps in the process. Where full automation
has the attraction of reduced manpower requirements,
selective automation will normally increase the likelihood
of success and potentially results in optimum utilization
of manpower with maximum return on investment.
CUSTOM AUTOMATION
Custom automation of polyurethane materials
testing using visual programming tools
Steven E. Robbins and Michael E. Rusak
Air Products and Chemicals, Inc., Allentown, PA, USA
Polyurethane foam physical test measurements are funda-
mental to characterizing end product uses and determine
economic feasibility. Visual programming tools were used
as the basis for integration of diverse hardware and
software necessary in this custom application development.
The visual environment improves system operations and
minimizes the need for extensive training. This presen-
tation described some of the technical approaches used in
automation of data acquisition, instrument and robot
control, and system management.
Automated compound storage and retrieval sys-
tems-providing a backbone for high throughput
screening programs
Scott C. Atkin and R. Bruce Jamieson
SAGIAN, Inc., Indianapolis, IN, USA
As High Throughput Screening technologies are imple-
mented in pharmaceutical and agricultural compound
discovery processes, the rate limiting step in successful
screening programs becomes the ability to handle the
’upstream’preparation of potential compounds. Specific-
ally, as HTS processes become robust within an organiz-
ation and truly high throughput there comes an ever
increasing demand for more novel compounds to screen
with improved access to existing libraries. Combinatorial
chemistry and acquisition programs can accelerate the
identification of new compounds. However, without
increasing manpower, the preparation ofthese compounds
can only be accomplished with automated systems.
Automated Storage and Retireval Systems (ASRS) allow
for the rapid retrieval of existing compounds for use in
HTS programs. A common requirement for many
compound management systems is the retrieval of an
archive compound from a central storage facility. Subse-
quent steps may include transferring a sub-sample to
another container for distribution to an internal HTS
laboratory, transfer and dissolution tbr shipment and/or
short-term storage, creation of’daughter’ microplates for
immediate use, storage, or shipment, or other processing
Integration oflaboratory automation for theHuman
Genome Project
William Lee, Eric S. Lander, Trevor L. Hawkins
Whitehead Institute/MIT, Center for Genome Research, Cam-
bridge, MA, USA
and Glynn Searl
CRS Robotics Corporation, Burlington, Ontario, Canada
There is a major need for the development of a system
which can accomplish the integrated tasks of DNA
isolation and proceed with purification and the set-up of
sequencing reactions. The authors demonstrated the
feasibility of such a system from both a biochemical and
engineering perspective. The authors are collaborating
with CRS Robotics Corp., Packard Instruments, Tecan
US and Techne Include to design and construct a
factory-style laboratory system. The major component of
the system is an articulate CRS 255/A robotic arm which
is track mounted. The deck of the robot contains several
new/modified XYZ robotic workstations, a novel thermal
cycler with automated headed lids, carousels and custom
built plate feeders.
Biochemically, the authors employed their solid-phase
reversible immobilization (SPRI) technique to isolate and
manipulate the DNA throughout the process. The system
is flexible and can be modified relatively easily. In this
way, one system can be used to accomplish many different
biochemical tasks.
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An integrated system for automated radio iodina-
tion
Andy Chang, Greg Bennett and Randy Yen
BioAnalytical Technology Department, Genentech, Inc., South San
Francisco, CA, USA
An automated robotics system was developed to perform
protein-labeling experiments involving radioisotopes. The
reason for integrating this system is to allow people to
minimize exposure to radiation, not for high throughput
nor for running experiments at a high volume. The system
consists of a m HP ORCA arm and four syringe pumps.
It is small enough to reside behind appropriate shielding
inside a chemical hood from which a charcoal filter traps
volatile radioactive molecules. A Visual Basic software
program was written to control the robot and to provide
a user interface for scientists or technicians. The user can
easily change parameters and/or create new methods
without having to know programming for the robot. This
system addresses safety concerns by reducing human
exposure to high levels of radioactivity, offers improved
reproducibility and reduces manpower needs.
The robotic automation of the determination of
doses from metered dose inhalers under a wide
range of simulated patient usage conditions
Andrew Monk
Department of Robotic Automation, Thurnall PLC, Manchester,
UK
This system described is an automated system proyiding
an repeatable method for handling and firing Metered
Dose Inhalers (MDIs) into collection apparatus, measuring
loss and determining dosage. The primary elements of the
system are: a gantry robot system, shaker/stirrer mechanism,
analytical balance, dose collection facility with associated
washdown unit, and an autosampler to provide samples
for HPLC analysis. The system provides a cost effective
and flexible alternative to manual testing.
Custom engineered automation for scientific re-
search
D. D. McCampbell, M. F. Fischer and C. E. Ball
Midwest Research Institute, Kansas City, MO, USA
Midwest Research Institute (MRI) has been providing
contract scientific research for over 50 years, in fields such
as energy, environmental, health, and transportation. The
automation group is a multidisciplinary group with back-
grounds in mechanical engineering, engineering design,
artificial intelligence, computer programming, machine
vision, analytical chemistry, and biology.
MRI’s specialists have developed robotic systems to
increase the throughput and precision of such tasks as
natural pesticide screening, oncogene inhibitor screening,
biological matrix extraction, and food product analysis.
Some of the custom systems developed by the automation
group at MRI were discussed in this presentation.
CHEMICAL ANALYSIS
Intrinsic viscosity measurement using a laboratory
robot
Philip J. Farrelly
Hudson Control Group, Springfield, NJ, USA
The presentation described the design and development
of a robotic system to fully automate the measurement of
intrinsic viscosity of polyester materials for a major petro-
chemical manufacturer. The topics covered included:
system design overview; identification of technical chal-
lenges; required innovations in hardware and software;
software development; operational methods; and future
expansion.
The design, construction, testing and implementa-
tion of an automated robotics system
Juan C. Cadavid and Marie Sabo
Clairol, Inc., Stamford, CT, USA
Keeping in line with today’s requirements, the Quality
Assurance group at Clairol was faced with the task of
doing more with less; i.e. they were confronted with the
challenge ofmaking more efficient use of their time. After
a careful evaluation ofpossible alternatives, an automated
robotics system was selected to perform the most time
intensive analyses in QA’s daily workload as well as the
ones with the most sample throughput. These analyses
were identified to be the determinations of % total
alkalinity, % fatty acid, and Brookfield viscosity.
Both the total alkalinity and the fatty acid analyses
were implemented using existing analytical autotitrator
methods. The existing Brookfield viscosity technique (on
a dye/developer mixture) was significantly modified due
to physical constraints in automating the method.
The robotics system is capable of handling 130 samples
per day with 10 possible combinations of analysis. The
possible combinations are determined via bar code
scanner from a preprinted list of bar code labels for each
sample. This information is sent to the top level user
interface program Visual BasicTM, an object-oriented
programming language which operates from the easy-to-
use WindowsTM platform. The intelligence and optional
help features incorporated into the interface permit
operators to obtain results with minimum supervision.
A description of the automated system was presented,
along with the requirements posed to the system, the
hardware and software utilized, and the system validation
schemes.
ADVANCED TOPICS
An approach to use low-budget-imaging to automize
the detection of liquid-liquid interfaces in labeled
test-tubes
Manfred Jungke, Marius Voehringer, Karlfried
Doerr, Christian Lehmann and Jens Luettge
Fachhochschule, Frankfurt am Main, Germany
The main objective of this work was to investigate whether
low budget hardware components, combined with a
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standard PC, could be used to solve a complex task of
liquid-liquid extraction in labeled test-tubes. The goal
was to detect the separation layer of two transparent
colourless liquids, with different refraction coefficients.
The tubes may have white labels or light colour labels.
The labels may cover up to half of the circumference of
the test-tube, they may be machine printed or manually
written. There is no need to predetermine the position of
the label. The method was tested by using an example of
plain water and sunflower oil that had been carefully
added before.
One major task was to set up a solution with low cost
commercial consumer components such as a black and
white camera module, and a consumer PC-video-digitizer,
which was used as a frame-grabber. The components were
successfully mounted on a Zymate py-plate and were
integrated in the automation process under control of a
Zymate II System. The method was developed by training
electrical engineers in automation tasks in an educational
environment.
This work was supported as a research project by the
Hessian Ministry of Science and Art.
Evolution of machine vision enabled automation:
from the factory floor to the laboratory bench
James H. Beyer, Michael E. Dobbs, Paul C. Olsztyn
Vision Instruments, Inc., Ann Arbor, MI, USA
and Julie Erb
Proctor & Gamble Company, Cincinnati, OH, USA
Historically, the application of machine vision to auto-
mation problems has been an expensive, one-of-a-kind
effort, requiring special purpose hardware and highly
skilled engineers to support an application. The high cost
ofdeveloping and maintaining a vision enabled automation
application restricted its deployment to large volume/high
margin manufacturing tasks, such as welding in the auto-
motive industry and circuit board soldering in the
computer industry. The increasing computational power
of commercial personal computers, coupled with their
decreasing cost, has enabled a new machine vision
paradigm. PC hosted image processing software can now
be combined with robotics and other automation com-
ponents for a fraction of the cost of systems created just
a decade ago. This decreased cost enables machine vision
to move from large scale factory automation, to smaller
scale laboratory automation. Vision Instruments Inc. has
introduced a series ofvision enabled products which allow
the automation of laboratory processes previously not
amenable to automation effort. This presentation examined
the evolution ofimage processing techniques from itsDOD
roots to its application in the modern laboratory. It also
showed the implications of this evolution for the auto-
mation of laboratory procedures used in high throughput
screening and microbiological counting and classification
techniques.
A modern robotic automation technology for
material handling applications
Karl Sharicz, Ed Fournier, David Feindel and Marc
O’Mara
Asyst Automation Inc., Wilmington, MA, USA
Like most manufacturing environments today, the semi-
conductor industry faces many of the same challenges as
those involved with pharmaceutical drug discovery and
development. The common denominator in both industries
is that traditional methods are no longer sufficient in
satisfying the demands for increased yields, reduced costs,
and accelerated time-to-market. Comprehensive solutions
that essentially redefine the work process and help
organizations remain competitive into the next century
are required. At the same time, these solutions must offer
a total systems approach that allows organizations to
retrofit and extend the usefulness of existing facilities, as
well as build new cost-effective facilities. In essence, these
solutions must provide integrated strategies with a
financial and technological pay-off.
Automation, through the use of robotics technology, has
made a significant contribution in process optimization
and has led organizations toward realizing the goals
prescribed by these new demands. For the semiconductor
manufacturer, the evolution of more advanced chip
designs, larger wafer diameters, safer and more reliable
material handling, and needs for reduced particulate
contamination have helped create increased opportunities
to apply robotic automation.
Since 1981, Asyst Automation engineers have served the
needs for the semiconductor manufacturer by pioneering
the field of contamination-free robotic material handling
systems. These systems enable manufacturers to safely
store, retrieve and transport material during the manu-
facturing process. Materials include bare silicon wafers,
wafer containers, bare reticles, and reticle containers. By
designing the system to work within its own ’mini-
cleanroom’ environment, Asyst Automation has helped
semiconductor manufacturers reduce space requirements
and recover valuable cleanroom floor space.
This presentation, through graphic illustration and
videotape, showed robotic material handling in action
and demonstrated how the material storage, retrieval,
transport, and management process applies in a variety
of configurations and applications. These systems provide
data links to other aspects of the manufacturing process;
the technology is easily learnt and mastered by production
personnel through a graphical user interface provided by
the OS/2 Presentation Manager control software.
MANAGING LABORATORY AUTOMATION
A team approach to the transfer of robotics to a
QC environment
j. R. Tricome, N. Muhammad, S. W. Swieck and
J. j. Rice
Bristol-Myers Squibb Company, Syracuse, NY, USA
In today’s competitive environment in the pharmaceutical
industry and with increased emphasis on productivity and
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efficiency, a team approach is essential to successful imple-
mentation of a robotic system in a QC environment. A
QC initiative was undertaken at Bristol-Myers Squibb in
Syracuse to implement a robotic system to analyse
Penicillin fermentation whole broths on a 24-hour basis.
This team effort has resulted in the introduction ofrobotics
to the QC laboratories and a smooth transition to a fully
automated analysis technique.
Approaches to automation for pharmaceutical
analysis
Alan Wickman
G. D. Searle, Skokie, IL, USA
Automation has been an ongoing endeavour within G. D.
Searle’s analytical group for the past 12 years. Initial
successes were with automation ofdissolution testing. This
was followed by not so successful attempts at automating
other sample analysis techniques. With much hard work,
lessons learned, and persistence, all major analytical tests
have been automated. While automation has meant that
analysis capacity has been increased, it has also presented
new problems and challenges.
This paper discussed what has been automated at G. D.
Searle, what works best and why, the problems, the
challenges and a view on what the next five years will
bring.
Regrouping, reforming and re-engineering: applying
robotics to new challenges
Stephen Scypinski, Theodore Sadlowski and
John Baiano
Analytical Research and Development, Hoffmann-La Roche, Inc.,
Nutley, NJ, USA
At the ISLAR meeting over the past several years, many
management session and plenary talks have dealt with
the reality of’ doing much more with less.., faster!’ Most
recently, Dr Phillip Lane of R. W. Johnson PRI spoke of
’The reality of the 90s’. The number of mergers,
acquisitions and consolidations in our industry has
intensified. All of these actions always result in more work
for less people. Hammer and Champy’s 1993 book
Re-engineering the Corporation spelt out what will become
reality for a company of the 90s and into the next century
in that companies will surely improve the way we, as
American corporations, conduct business. Most inter-
estingly, re-engineering relies heavily on information
technology and automation, which is not too surprising.
Indeed, many’of the practices spelled out in the case
studies documented in their book could not have even
been thought about 15 to 20 years ago.
If one extrapolates the re-engineering fever to the field of
analytical chemistry, the use of automation will con-
comitantly increase over the next several years as well.
Such an attitude will require a fresh look at projects and
situations that can be automated. The ability oflaboratory
personnel to ’think out of the box’ will dictate their rise
or fall as successful analysts.
Some of the newest challenges at Roche were discussed
in this presentation.
Laboratory automation: a critical tool in com-
petitive, regulated industries
Lane Gehrlein
Schein Pharmaceuticals, Carmel, NY, USA
Multisource pharmaceutical companies face increasing
demands for fast and efficient research and development
programmes. Large domestic pharmaceutical companies
are developing generic drug programmes and foreign
pharmaceutical companies are also entering into the
generic drug market. In order to stay competitive,
companies must increase the number of new product
introductions, since the market share for each product is
divided up among an increasing number of competitors.
Laboratory automation has played an important role in
Danbury Pharmacal’s ability to develop an increasing
number of new generic pharmaceutical products with
minimal increases in R&D personnel. Laboratory auto-
mation has also been very effective for reducing the impact
of increasing government regulatory requirements on
pharmaceutical R&D programs. The laboratories employ
automation in eight areas which have demonstrated a
positive impact on productivity: cleaning validation-
sample testing; process validation-sample testing; product
assay and content uniformity; dissolution; data acquisition
network; LIMS; method validation; and raw material
release.
Automation in a highly regulated industry can be very
productive when properly implemented and validated.
Regulation can be equated with consistency which is
exactly what is obtained from automation. All ofthe above
automated procedures have been designed to deliver data
which has been validated and reports which directly
reference that data. No additional manipulation of data
or reformatting of results is needed. Auditing of these
reports is easy and fast, because the auditor knows exactly
what to look for and where to find it. Automation will
be a major contributor towards staying competitive in
today’s highly regulated industries.
Digging out with a robot
Milton Levenberg
Abbott Laboratories, Abbot Park, IL, USA
As in every other pharmaceutical company, the chemist/s
at Abbott Laboratories are totally dependent on a rapid
return of spectroscopic data on their intermediates and
synthetic products to ensure that their chemical reactions
are on track. Eight years ago the chemists at Abbott often
had to wait three days to a week to receive this data, and
had to start new reactions without this data, hoping the
previous step performed as expected. That this was an
unacceptable situation was clearly recognized by the
Abbott chemists and the management of the spectroscopy
area.
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This presentation discussed the general approach used to
analyse Abbott Laboratories’ needs and to provide totally
automated sample preparation and running ofbothNMR
and mass spectrometric samples. Systems by which the
chemists log their own samples into our database have
been developed. A Zymark robotics system does the entire
sample preparation and insertion into the spectrometer.
NMR spectra are plotted directly in the client’s lab. The
spectroscopy staff need only provide samples to the robot,
fresh supplies (solvents, tubes etc.) and routine main-
tenance, but no actual sample handling or spectrometer
operation. The effects of this automation on throughput,
sample turnaround time, and cost per spectrum were
presented.
Getting smart with automation
Richard Kramer
Instrumentation Development Group, Bristol-Myers Squibb
Pharmaceutical Research Institute, Princeton, NJ, USA
Laboratory productivity and quality issues have given
way to business issues as the driving force behind
automation and in pharmaceutical R&D in recent years.
This shift brings with it unprecedented opportunity for
automation where it can be related to meeting business
objectives. Unfortunately, not all of the driving business
issues are pretty: the budget restrictions, staffing limit-
ations, and organizational changes that we live with today
require that we thoroughly understand the role automation
will play in the new climate. We have found that we are
not merely charged with engineering the physical auto-
mation in the laboratories, but also engineering the
strategy for the evolution of automation. We had to get
smart.
In the author’s R&D environment, getting smart was
achieved through two distinct methods, which were
discussed in depth: getting smart about automation, and
getting smart from automation. The presentation con-
sidered the relationship of risk management strategies,
and how education, investment and partnerships are
ingredients ofmanaging automation growth. The chemist’s
role as in-house integrator was examined in terms of
the multitude of hats we have to wear. Also the lessons
learned from implementing automation were discussed.
Additionally, goals for automation technology need to be
tempered with realistic expectations. This presentation
focused on these issues and provided some operational
solutions for organizations facing many of these same
problems.
Economic justification of automation systems in
the Dow Chemical Company
Jonathan Zieman, Paul Morabito and Ramasamy
Tamilarasan
The Dow Chemical Company, Midland, MI, USA
Numerous robotic automation systems have been devel-
oped and implemented within the Dow Chemical Com-
pany. These systems have found homes in production
quality control laboratories, analytical laboratories, and
R&D departments. The complexity of procedures auto-
mated within the company has varied, ranging from
sample preparation for biological tissue analysis to
polymer sample hot dissolution to polymer physical
testing. Automation capabilities are currently available
that can reliably perform most of the common laboratory
procedures such as weighing, dilution, filtration, vial
manipulations, liquid handling, incubation, and inter-
facing to instruments etc. The developed capabilities
along with the new emerging technologies have enor-
mous automation potential in many areas within the
company.
As with all capital investments, economic justification
must be evaluated for the automation impact and return
on investment (ROI). It can be difficult to identify and/or
quantify all the major variables needed to adequately
determine the automation impact/ROI, especially for the
first-time user. Lack of suitable information could result
in not funding a project that would save the company
money and increase productivity. ROI data acquired
from several automation systems in operation over the
past couple of years was used to more formally address
future justifications. The issues from these systems were
presented to help identify topics to consider if automation
plans are in your future.
VALIDATING LABORATORY AUTOMATION
Evaluating the reliability of software
Laboratory automation of the 1990s: goals, expect-
ations and business needs
W. Jeffrey Hurst and Robert A. Martin Jr.
Hershey Foods Technical Center, Hershey, PA, USA
The laboratory of the 1990s is not immune to the trends
facing American industry. For many years, laboratory
professionals have felt that they could somehow be isolated
from the realities of business. Laboratory automation was
targeted as a panacea for a multitude ofissues dealing with
laboratory productivity. There has been a shift in
industrial research and development, requiring labor-
atories to refocus their efforts and continuously evaluate
the many facets of laboratory operations including
financial objectives along with laboratory automation.
Charles A. Snipes
FDA, Rockville, MD, USA
Current computer industry standards for software require
a written validation plan that will include the following
elements:
(1) Design specifications (exactly what the program is
intended to do and exactly how it is intended to do
it, detailed, both high level and low level, with
predetermined criteria for acceptance ofthe program,
and descriptions of: hardware to be used, algorithms,
file structure, limits and parameters to be measured,
error and alarm messages, configuration, communi-
cation links among subprograms and to equipment
and to other systems, and security measures).
(2) Risk/hazard analysis.
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(3) Testing plans: Developmental, including structural
analysis of all individual decision points (in the
modules before integration), and testing of worst case
conditions at operational limits, of alarms, of error
routines, and ofexecutable statements. Installation, for
installation testing of the software within the environ-
ment where it has been designed to function.
(4) Evaluation of test results, particularly as to how they
demonstrate that the design specifications have been
met.
(5) Change control/revalidation procedures.
(6) Documentation about who is responsible for approving
and for executing the validation plan.
(7) Archiving the whole of the above, including in
particular all versions of the design specifications and
in particular specific test results, rather than pass/fail.
(8) Especially important are the design specifications, as
these are the heart of a validation.
Written development standards (for overall development)
and written programming standards (for the work of
individual programmers) are also of importance.
Development and validation of an automated drug
content and degradation profile analysis method
for pharmaceutical tablets
John R. Stanley
Pharmaceutical Technologies, SmithKline Beecham Pharmaceut-
icals, Hertfordshire, UK
An automated bulk tablet drug content assay application
for the HPLC analysis of pharmaceutical tablets has been
developed and validated using a Zymark BenchMate
Tablet Processing Workstation (TPW) with EasyFill
sample collection module (EZ). The first part of the
application consisted ofthe development and optimization
of a Zymark TPW method for the homogenization of
tablets and the extraction of the drug component of
interest from the tablet matrix.
The second part of the application was the development
of a protocol to show equivalence between the automated
method and the pre-existing manual method for the
extraction of drug for both bulk content drug assay and
degradation profile analysis. This protocol included an
assessment ofTPW processed samples that were transferred
to vials by the EZ for subsequent off-line HPLC analysis.
The third part of the application was performance
qualification validation for the equivalence protocol and
interpretation of the data generated. Advantages and
disadvantages of the approaches undertaken for the
development and validation of the automated procedure
were discussed.
Development and validation of a Zymate PyTech-
nology potency robot equipped with a tablet pro-
cessing workstation and on-line HPLC
Daniel W. Barrow
Bristol-Myers Squibb, New Brunswick, NJ, USA
A potency and degradant analysis robot has been success-
fully developed and validated for use with tablet and
whole encapsulated dosage forms. The system is based on
a Zymate PyTechnology robot equipped with a Tablet
Processing Workstation PySection and on-line HPLC.
Active drug ingredients and degradants are extracted
from solid dosage forms using a high speed homogenizer.
Filtration is performed by a custom filtration PySection
that uses standard membrane filters and dispenses filtrate
directly into the target test tube. Multiple dilutions are
possible using capped test-tubes. The high capacity, 50 ml,
test-tubes allow accurate dilutions and vigorous vortex
mixing, virtually eliminating evaporation through the use
of a robotic capping PySection. Final working solutions
are automatically injected onto the on-line HPLC. Total
sample capacity is increased through the use of a custom
waste diversion valve which separates hazardous extraction
waste from aqueous wash waste. Productivity gains of this
robotic method of analysis are approximately 100
compared to manual methods of analysis.
This robotic system has been successfully used in the
analysis of whole encapsulated dosage entities. The
presentation described system schematics and robotic/
methodology validation data including accuracy and
precision.
The validation of a Zymark Batch Dissolution
System for QC and R&D analytical laboratory
Muhammad Alburakeh, Charles DiLiberti and
Mattio Citardi
Barr Laboratories, Pomona, NY, USA
After considerable effort by the Batch Dissolution Project
Team, the Zymark PyTechnology-Batch Dissolution
Robotics Systems have been validated for use in the
authors’ laboratory as a fully automated dissolution
testing system. They support samples provided by the
QC and R&D areas, as well as process validation
samples. Each system was successfully validated with USP
apparatus I & II to perform on-line UV analysis, off-line
HPLC vial filling and storage, single and multi sample
point profiles, sample weighing and media exchange.
These systems were originally installed as serial systems
using telescoping shafts, filter tips and gravimetric media
dispensing. The upgraded Batch Dissolution Systems are
using volumetric media dispensing, standard 0"45 micron
membrane filters and standard USP dissolution shafts.
Some of the authors’ experiences, as well as frustrations,
and most importantly, successes in the transfer, pre-
validation and validation of the robotics systems were
presented.
DRUG DISCOVERY
An integrated and versatile system to rapidly
determine potency, selectivity and potential for
side-effects: from assay automation and data
management to result
j. Elands, C. Widmaier and M. Galvan
Marion Merrell Dow Research Institute, Strasbourg, France
In a continuous effort to optimize early drug discovery
the authors set out to automate the following tasks:
screening new compounds against a series of receptors,
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uptake sites and enzymes, to establish selectivity and
side-effect potential; development ofHTS assays; secondary
screening of HTS hits.
Task is run in batch mode: a single receptor/uptake
site per microtitre plate was used. Task 2 requires a
temperature/CO2 controlled incubator, a fluorescence
and UV/Vis plate reader and a luminometer--different
assay conditions are evaluated automatically and assays
are rendered compatible with a fully automated system.
Task 3 involves the evaluation of libraries of analogues
around a hit on the original assay and a series of assays
selected to assess selectivity for the target; assays of the
first task are also used in this stage.
Assays could not be run during long times. So a flexible
robotic system with an easy programmable GUI-based
Scheduler was needed. Details of the Zymark robotic
system used and examples ofscheduled assays were shown.
Assays are continuously adapted and new assays developed
for every HTS target. The end users need a flexible data
management package with powerful protocol management
incorporated. Compatibility with existing corporate data-
bases is essential. ActivityBase from idBS was found to
have nearly all these features included, idBS has proven
to be very flexible by adding those features that were
essential to our company. The architecture ofActivityBase
was also discussed.
A multi-functional microplate workstation as a
strategy for changing priorities
William S. Fillers and Diana K. Cohen
Sandoz Research Institute, Sandoz Pharmaceuticals Corporation,
East Hanover, NJ, USA
Shorter project lifetimes, changes in personnel and rapidly
shifting priorities require a flexible approach to high
capacity screening (HCS). A compact microplate robotics
platform capable of operating concurrent luminescent
and spectrophotometric assays was described. The oper-
ation schedule of the platform is determined by the ability
to generate plates for cell based, reporter gene assays
(RGA), while remaining workstation time is filled wth
assays which are less constrained by supply dynamics.
Sample preparation efficiency gains and conservation of
the compound library are made possible by sharing
sample dilution plates. Sustained output of 7500 samples
per day creates the opportunity for batch or concurrent
processing of primary and secondary screens. The cost
advantage ofrapid cycle time allows consideration ofmore
high risk opportunities. Concurrent operation of multiple
screens on a single HCS platform is an effective strategy
for rapidly generating large amounts of data for decision
making on competing approaches that require scarce
project resources.
Automating more for less
M. R. Kozlowski
Department of Screening, Geron Corporation, Menlo Park, CA,
USA
A goal oflaboratory automation is to replace human effort
with robotic labour in the performance of predictable,
repetitive laboratory operations. In an ideal world, this
approach frees up the human element to perform more
sophisticated and rewarding tasks. This goal is only
realized, however, when the automation of the task takes
less resources over the life of the project than simply
performing the task manually. Resources include such
things as human time, financial outlay (which can be
converted to human time via cost per FTE), and
down-time (which can be converted to financial outlay
via ’burn rate’). Resource-intensive aspects ofautomating
a task include training the robot, designing and testing
(or purchasing) special robot-operated equipment, and
managing the robotic system (for example, fixing ’crashes’).
Automation of certain tasks is often not undertaken
when the apparent resource requirement becomes too
great.
This presentation discussed ways to make more tasks
amenable to automation by decreasing the resource
output required to perform them with a robot. Two key
elements were focused upon: first, decreasing the need for
specially designed equipment, and the resultant expense
and delays. Many tasks can be performed by a robot using
standard, or slightly modified, basic laboratory equip-
ment. The second focus is decreasing resources lost
through robot failure. Simple robot ’babysitting’ tech-
niques were also presented.
The modular application of automation to high
throughput screening
j. v. Petersen, Jason Armstrong, Steve Hamilton
and Rick Stanton
Amgen Incorporated, Thousand Oaks, CA, USA
The Research Automation Technologies group at Amgen
is charged with development ofa coherent and responsive
automation strategy to accelerate the drug discovery
process. Success is measured by the timely application of
the appropriate technologies to research and development
applications. Due to the diversity and quick turnover in
research projects, the hardware and software needs to be
modular in design to facilitate the ease of development,
integration and maintenance.
The cornerstone of the High Throughput Screening
industry is the microtiter plate. A list of basic modular
operations for an assay are barcoding, liquid handling,
transporting, washing, reading and storage. Common to
all of these modules are sample interaction, data inter-
change, external control and internal status. A variety of
commercial devices and software provide a core function-
ality that requires further customization and enhancement
to provide a fully integrated robotic system. Examples of
several Amgen automated screening effors were reviewed
to illustrate how this module approach can assist in the
discovery of new therapeutic drugs.
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DISSOLUTION TESTING/VALIDATION
Evolution ofa rugged automated dissolution system
with high sample throughput
Richard Von Culin
Analytical Research & Development, Bristol-Myers Squibb
Pharmaceutical Research Institute, New Brunswick, NJ, USA
Automated dissolution testing has become a pharma-
ceutical industry standard with companies restructuring
and trying to do more with less. Automated dissolution
has been very successful for the robotics laboratory in
Ananalytical R&D, New Brunswick. An on-line UV
spectrophotometry robot has processed approximately
35 000 samples since 1989 and has accomplished uninter-
rupted dissolution runs lasting more than 50 hours. The
evolution of a highly productive and rugged on-line
dissolution system can be summarized in three main
developmental stages: system flexibility, system relability,
and efficient data management. System flexibility was
obtained by programming the robot to run multiple
dissolution methods. The system can run capsules, tablets,
different sample potencies, and different flow cell sizes
during a single dissolution run. The system has proven to
be very reliable over the past six years. The only service
performed routinely is preventative maintenance so the
system rarely fails to complete a dissolution run. Finally,
to further increase sample throughout, data management
functions were automated. Custom software was written
to electronically input all sample information into the
SystemV controller and to lead the final dissolution results
into the stability database. The evolution of this on-line
UV dissolution robot into a rugged and productive system
was presented.
The fibre optic method development was described,
together with the testing used to validate this system. The
dissolution throughput has increased considerably for
samples with interfering matrix. The fibre optic end
analysis has provided additional savings to the current
economical automated dissolution methods. This system
minimized the handling ofexperimental samples, providing
an added measure of safety to laboratory personnel when
handling very potent or sensitive materials.
Validation of vendor-supplied systems
Bruce Fowler, P. Michael Masterson and Clarence
Kemper
Kemper-Masterson, Inc., Belmont, MA, USA
The purpose of this presentation was to describe some
current issues and concepts relative to vendor-supplied
systems, such as LIMS, laboratory instrumentation, or
robotics. The presentation incorporated practical docu-
mentation techniques for optimizing qualification and
validation of vendor-supplied systems. The presentation
focused on the validation premise that user firms can
reduce the amount of effort and expense of qualification
and validation if they rely on vendor-supplied data and
information to support their systems-related activities.
The conclusions emphasized that vendor and users should
work more closely together to minimize the cost and effort
required to qualify and validate systems used for GLP
and GMP functions.
Establishing validation standards
Automated dissolution testing utilizing on-line
fibre optic probe UV analysis
Leonard J. Kostek, Paul K. Aldridge, David W.
Melvin, Brenda A. Williams, Karl Bratin and
Sonja Sekulic
Analytical Research and Development, Pfizer Central Research,
Groton, CT, USA
Automated dissolution testing has become a common
practice in the pharmaceutical industry. Generally, the
end analysis for the dissolution test has been an ultraviolet
spectrophotometric assay or an HPLC separation with
ultraviolet detection. The end analyses for both methods
have been performed off-line and on-line depending on
the drug product. For the past 10 years, automated
dissolution methodologies have encompassed vessel filling,
sample dropping, medium sampling and vessel washing
routines. Recent advances in fibre optic technology have
complimented the traditional systems by allowing in situ
analysis of the dissolution samples. The end analysis is
performed on-line with each dissolution vessel using a
robot manipulated fibre optic probe and interfaced to a
conventional ultraviolet/visible spectrophotometer. No
sample is removed from the dissolution vessels and no
filtration is required to eliminate background interference.
Various computer programs instantaneously calculate
the results and transfer the data to appropriate spread-
sheets.
Gregg Bell
Quality Control--Automation and Technology, Geneva Pharma-
ceuticals, Inc., Broomfield, CO, USA
In the more than 10 years that computer system validation
has been an area of concern within the pharmaceutical
industry, regulators, manufacturers, and system vendors
have been faced with the task of determining how these
systems should be documented. Although numerous
articles and guidelines on validation principles have been
published, the development ofwidely accepted validation
standards has been slow to evolve.
By developing company-level validation standards, signifi-
cant benefits can be realized in the areas of regulatory
compliance and business performance. This paper de-
scribed the benefits of establishing validation standards;
described practical techniques for the development and
maintenance of validation standards; and provided an
example of a validation standard for a company-level
computer system validation master plan document.
ADVANCED TOPICS/DATA HANDLING/DATA
MANAGEMENT
Computer modeling of laboratory automation
Wen-Jeng Li
Bristol-Myers Squibb Pharmaceutical Research Institute, Prince-
ton, NJ, USA
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Down sizing has made a lot of scientists consider that
automation will make up the loss of manpower in the
laboratory. Some of them had not thought of laboratory
automation previously. Some of them had some ideas
about what to automate, but most of them do not know
where to start, what to automate, or who to talk to.
Working as internal system integrators, we have the
responsibilities to educate our scientists about laboratory
automation, help them to identify potential areas, and
work out solutions with them. Describing our suggestions
with words and drawings alone sometimes cannot get the
message across. Most scientists do not envision automation
like engineers. Therefore, we started to use computer
modeling software to show the scientists how ideas can
work. Ifa picture is worth a thousand words, then moving
pictures must be worth thousands times more.
With the help of life-like animations, scientists can see
every step of their processes performed by an automated
system. Misunderstandings can be easily corrected in this
design phase. This helps to prevent financial losses and
minimize wasted time due to rework.
The integration of laboratory automation systems
with LIMS in a pharmaceuticalR&D environment
Marie Di Maso, Alain LeBlanc, Carolyn Wells, Judy
Wybrandts and Sam McClintock
Merck Frosst Centrefor Therapeutic Research, Kirkland, Quebec,
Canada
To obtain regulatory approval to market a new drug
product, long term stability studies are required to
demonstrate chemical and physical stability during the
indicated shelf life of the product. Under the current
changing regulatory environment, more extensive testing
and exhaustive documentation is required to support these
studies. This presentation described the process of
automating and integrating many of the steps required
to generate the appropriate data. A LIMS system is used
to set up the study protocols, log in samples for analysis,
collate data, produce reports, archive the data and
forecast workload. This system receives data from several
sources including an automated chromatography system,
balances, KF instruments, a Benchmate Tablet Processing
Workstation and a MultiDose dissolution system. The
process of validating and maintaining each of the systems
and the associated documentation was presented. The
methods development and optimization processes on the
robotic systems and the authors’ approach to issues
encountered were discussed. Emphasis was placed on the
integration of the systems and the flow of information
between the system components.
Applications of Visual Basic in laboratory auto-
mation
Martin Echols
Nycomed Inc., Collegeville, PA, USA
and Mark F. Russo
Industrial BioCatalysis, Wynnewood, PA, USA
The Visual Basic programming system for Microsoft(R)
WindowsTM is quickly becoming one of the most promi-
nent custom application development tools for the
automated laboratory. Visual Basic combines a simple
programming language and an intuitive graphical user
interface development environment with a wide range of
built-in and third-party software libraries. Visual Basic
software libraries are available for purposes such as: data
acquisition, serial communications, motion control,
scientific graphing, statistics, neural networks, multi-
media and even laboratory robot control. This ease-of-use
and continually increasing number of pertinent software
libraries makes Visual Basic attractive for developing
custom software components for automated laboratory
systems.
The heart of any laboratory automation programming
environment is its ability to communicate outside of its
own boundaries. Visual Basic provides many ways to
accomplish this. The authors detailed several of these
communication mechanisms by discussing a variety ofreal
laboratory automation applications using Visual Basic.
These examples covered Serial and IEEE 488 com-
municaions, Dynamic Data Exchange (DDE), Dynamic
Link Library (DLL) calls, and Object Linking and
Embedding (OLE). The access of databases and local
area networks, as they pertain to laboratory automation,
as well as Zymark’s Systems V Controller was also
discussed.
Automation of a Houillon viscometer
Katherine S. Bonar, Robert N. Sanders and
Donald R. Blevins
Albemarle Corporation, Baton Rouge, LA 70898, USA
Viscosity measurement is an important part ofAlbemarle
Corporation’s R&D lubricating oil programme. Re-
searchers can generate more samples in a given time
period ifsample size is small. An ISL Houillon viscometer
was purchased so that small volume samples could be run.
Using this manual instrument increased the workload
because previously fewer large volume samples were being
run on an automated viscometer. Fast turnaround is
needed to allow efficient progress in research projects. It
was concluded that automation would make the measure-
ment less time-consuming and costly. Robotics would also
eliminate any potential operator inattention problems due
to boredom.
The Houillon was automated with Zymark PyTechnology
robotics. Since this application is the first automation of
a Houillon viscometer, custom designs were needed. A
special pipet hand for handling small volume pipet tips
was devised. A communications interface between the
Zymark computer and the Houillon computer was also
designed to detect instrument status and to exchange
sample identification and results.
The automation has produced substantial savings in
operator time. These savings will return the capital
invested after running about 6000 samples. It has also
resulted in the researchers receiving answers sooner,
because the robot can operate overnight. Another benefit
was demonstrating a robot’s usefulness and potential in
an R&D setting to skeptics in the organization.
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Progress toward standard commands for modular
analytical instruments
Gary W. Kramer, Peter J. Grandsard, Torsten A.
Staab and Uwe Bernhoeft
National Institute of Standards Technology, Chemical Science and
Technology Laboratory, Analytical Chemistry Division, Gaithers-
burg, MD, USA
The concept of building automated analysis systems by
interconnecting standard modular instruments offers
great potential to reduce the costs and complexity of
system integration. The Consortium on Automated
Analytical Laboratory Systems (CAALS) has been
working to delineate the requirements for modular instru-
ments. Previously, CAALS has described an architecture
for fully automated laboratories, developed the CAALS-I
Communication Specification for instrument-to-controller
messaging, and enumerated behaviours that devices
should exhibit for good system citizenship. Currently, with
the assistance of CAALS members and other experts in
analytical and clinical chemistry automation, an attempt
is being made to define a small, but powerful set of
standard commands for the remote control ofinstruments.
The approach is simple, abstract, and enabling. Since
many analytical instruments are already computer-
controlled and capable of storing externally defined
methods, there is little reason to attempt standardization
at the device command level, rather the approach is to
develop a standard mechanism for invoking such stored
methods. In this way, system control can be achieved
without requiring instrument manufacturers to give up
their existing methods ofprogramming their instruments.
A systematic approach to error and exception
handling in automated laboratory systems using a
machine vision example
Peter J. Grandsard, Torsten A. Staab and Gary W.
Kramer
National Institute ofStandards Technology, Chemical Science and
Technology Laboratory, Analytical Chemistry Division, Gaithers-
burg, MD, USA
Managing errors and exceptions is a system requirement
that is commonly omitted in the initial designs for
laboratory automation applications. Ad hoc approaches
for handling such unexpected events are often added
during system implementation, often reducing a carefully
designed control system to ’spaghetti code’. Over the
past five years, the Consortium on Automated Analytical
Laboratory Systems (CAALS) has developed and pro-
moted the concept of modular instruments as build-
ing blocks for automated systems. A requirement of
CAAL’s modularity concept is the development of a
systematic, modular approach to the handling of un-
planned events.
Classically, unscheduled event handling has been carried
out in three steps: event detection, event reporting, and
event remediation. This process would be more modular
ifa fourth activity, event classification, was added between
detection and remediation. In this paper, the authors
presented their recent efforts using machine vision as an
example to manage errors and exceptions in the operation
of our Laboratory Automation System Testbed. The
following issues were addressed: the classification of
unplanned events; the level of synchronization between
error/exception detection and remediation; and the
manner by which an effected module returns to its normal
operating state. Underlying the treatment of all these
issues is compliance to the module behaviour requirements
of the CAALS control model. Some different recovery
procedures were illustrated with real examples.
Automation integration, and regulation
Quo Vadis?
Frank A. Settle
VMI Research Laboratories, Virginia Military Institute,
Lexington, VA, USA
What is the current state of automation in today’s
analytical laboratories and where is it going? Has the ’fish
in-knowledge out’ paradigm been implemented with
automated, integrated, systems, or does automation exist
only on isolated islands? This presentation outlined
different approaches to laboratory automation in regulated
environments, discussed the advantages and limitations
of each, and cited case studies illustrating each strategy.
The synergy between the flow of samples and the flow of
data through automated systems was addressed.
The CAA (Contaminant Analysis Automation, Depart-
ment ofEnergy) and CAALS (Consortium for Automated
Analytical Laboratory Systems, National Institute for
Standards and Technology) hardware and software
standards for integration of automated devices into
systems were presented. Advantages of using these
standards were discussed, as well as problems encountered
in their implementation.
Finally, the path to full laboratory automation via ’plug
and play’ standard laboratory modules (SLMS @ Scibus)
was projected. The ultimate objective of this strategy is
to make laboratory automation as easy as office automation
through the use of standardized hardware interfaces and
software drivers.
DRUG DISCOVERY/HEALTH SCIENCE
Automated compound preparation for high through-
put screening
Mark Beggs
ZENECA Pharmaceuticals, Macclesfield, UK
High compound throughput is a key requirement in
empirical screening programmes aimed at pharmaceutical
lead identification. The initial compound dilution and
distribution processes that form a common ’front end’ to
many high throughput screens can benefit significantly
from effective automation. The primary need was for a
system that could accommodate large numbers of micro-
plates and perform the necessary liquid transfer operations
accurately and reliably. This capability has been provided
by an appropriately configured Zymark Microassay
System. Deployment of this system at ZENECA Pharma-
ceuticals has facilitated a significant increase in compound
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throughput. The rationale behind automating compound
dilution and distribution, the capabilities provided by the
system and the resulting benefits were described.
Design of track based automated ELISA assay for
use in high throughput screening
determine specific parameters ofa biochemical system (for
example, neurotransmitter receptor availability) important
to normal organ or tissue function. Often, multiple plasma
radiochemical assays including a series of labeled metab-
olite correction determinations must be made for every
quantitative PET procedure, requiring additional per-
sonnel working in a potentially hazardous environment.
Jeffrey A. Guss, Joe j. Yacobucci, Janet M. Kolb
and Derek J. Hook
Bristol-Myers Squibb, Biomolecular Research, Wallingford, CT,
USA
Drug discovery requires large quantities of samples to be
assayed and evaluated in a timely fashion. The screening
process contains routine mundane activities which need
to be carried out in order to find novel compounds for
specific therapeutic targets. Unfortunately, people are too
expensive and can introduce variability to the results of
an assay. So most companies interested in drug discovery
automate to ensure accuracy of the results and to make
better use of time. A popular assay type is the ELISA.
This incorporates liquid handling, shaking, incubating,
plate washing, and reading the end point. When creating
an automated platform for this type ofassay, an assortment
ofvariables must be addressed if the assay is to be success-
fully implemented. Reagents can be light and/or tem-
perature sensitive, and volumes of liquid to be handled,
sample apacity of the system, and incubation times are
just some of the variables to be considered for the science
of the assay. The physical layout and overall design of
the automated system has other needs. Communication,
which is both active and has conformation, whether or
not the system is stationary or track based, type of liquid
handling station, peripherals, and space requirements are
some design variables. Special requirements of the system
may include: reagent cooling and/or heating, filtration,
handling radioactive reagents, system waste, and external
reagent pumping stations. There are two other items to
consider when automating an ELISA, or any other type
of assay: development time and cost. If an automation
project such as this one is to be successfully designed and
implemented in a timely fashion, co-operation between
integrators and scientists is a necessity.
To help overcome this potential limitation ofquantitative
imaging studies, a commercial laboratory robot system
(Zymate PyTechnology II Laboratory Automation Sys-
tem) was interfaced to standard and custom laboratory
equipment and programmed to perform rapid radio-
chemical assays necessary for plasma input function
determination in quantitative PET studies in humans and
baboons. A Zymark XP robot arm was used to carry out
two assays" (1) the determination of total plasma radio-
activity concentrations in a series of small-volume whole
blood samples and (2) the determination of unchanged
(parent) radiotracer in plasma using only solid phase
extraction methods. Steady steady robotic throughput for
determination oftotal plasma radioactivity in whole blood
sa,mples (0"350 ml) is 14"3 samples/hour, which includes
automated centrifugation, pipetting, weighing and radio-
activity counting. Robotic throughput for the assay of
parent radiotracer in plasma is four to six samples/hour
depending on the radiotracer. Percentage of total radio-
activities present as parent radiotracers at 60 minutes post
injection of 25 ___
5"0 (N 25), 26 __
6"8 (N 68), 13 __
4"4
(N=30), 32___ 7"2 (N= 18), 16___4"9 (N=20), were
obtained for carbon 11 labeled benztropine, raclopride,
methylphenidate, SR 46349B (trans, 4-[(3Z)3-(2-dimethyl-
amino-ethyl) oxyimino-3 (2-fluorophenyl)propen-l-yl]-
phenol), and cocaine respectively in baboon plasma and
84 __+ 6"4 (N= 9), 18 __
11 (N= 10), 74 __
5"7 (N= 118)
and 16 __
3"7 (N 18) for carbon-11 labeled benztropine,
deprenyl, raclopride, and methylphenidate respectively in
human plasma. The automated system has been used for
more than four years for determination of unchanged
tracer in plasma for seven different carbon-11 labeled
compounds used routinely in the authors’ laboratory.
The robotic parent compound assay runs unattended
and includes automated clean-up procedures that elim-
inates all human contact with plasma-contaminated
containers.
Automated plasma radiochemical assays for quan-
titative functional imaging using a Zymark XP
laboratory robot
Research for this project was supported by USDOE,
OHER, and NIH Grants NS- 1538, NS- 15380.
David L. Alexoff, Colleen Shea, Joanna S. Fowler,
Payton King, S. John Gatley, David J. Schlyer and
Alfred P. Wolf
Chemistry Department, Brookhaven National Laboratory, Upton,
3;Y, USA
Positron Emission Tomography (PET) is a nuclear
medicine imaging technique that allows the quantitative
observation of the time course and spatial distribution
of positron-emitting radiopharmaceuticals in an organ
(typically the brain or heart) of an awake human subject
after intravenous injection. Combined with plasma radio-
activity measurements and a validated mathematical
model, this tissue radioactivity data can be used to
Robot-assisted synthesis of radiopharmaceuticals
labeled with high activity positron emitters
C. Brihaye, C. Lemaire and A. Luxen
Cylotron Research Center, University of Liege, Sart-Tilman Bat
B30, B-4000 Liege, Belgium
Positron Emission Tomography (PET) is becoming an
increasingly important tool for studying physiological,
biochemical and pharmacological functions at a molecular
level in living man, whether in health or in disease. Radio-
chemical methodology constitutes the most important
base for successful functioning of a PET group in the
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routine production and development of radiopharma-
ceuticals. Automatic robotic radiosynthesis is more desir-
able to avoid excessive radiation exposure to operatives,
although the labeling of radiopharmaceuticals with high
activities (>18500 Mbq) of position emitter (laF, IC,
13N) by remote control is feasible. The preference for
robotic radiosynthesis exists, because it appears to be more
versatile, and therefore more useful for research. In the
Cyclotron Research Center of the University of Liege, a
robotic system has been developed base on the ZymateTMII
Laboratory Automation System (Zymark Corporation).
The software control is EasyLab PlusTM, and routines for
several modules, more specific to the particular radio-
synthesis were designed and fabricated in house, including
a column for the separation of [aF]fluoride from
irradiated water, Sep-PakTM and conventional chroma-
tography systems, ovens for evaporation equipped with
optical levels probes, a microwave oven to rapidly heat
vials. Special sectors were designed for collecting fractions
from a chromatographic column and automatic injection
in an HPLC system, as well as for formulating the.
injectable solution.
Complete routine productions of[-laF-I Altanserin, 4-[18F]
Fluorotropapride, 6-[laF] Fluoro-L-Dopa and 2-[ la]
Fluoro-L-Tyrosine are conducted weekly, including the
labeling of the radiopharmaceuticals, the quality control
and the formulation of the injectable solution.
Automated sample preparation methods for DNA
amplification by PCR
Larry D. Sutton, Werner W. Wilke and Ronald N.
ones
Medical Microbiology Division, Department of Pathology,
University of Iowa College of Medicine, Iowa City, IA, USA
An automated DNA extraction system was developed
which was capable ofextracting DNA by several methods.
Extraction was accomplished using a Zymate XP robotic
system with a centrifuge, master laboratory station with
remote dispenser, capping station, vortexer, centrifuge
hand, 200gl eight channel pipetting hand, one ml
pipetting hand and a combination syringe-gripping hand.
Peripheral equipment included Boekel minirefrigerator
and freezer, and a Hitachi U-2000 double beam, scanning
UV-Vis double beam spectrophotometer automated using
Zymark’s generic RS-232 interface. The system extracts
the DNA from the sample and quality controls the
preparation by measuring absorbences at 260 and 280 nm.
Samples are processed in 1"5 ml screw-capped micro-
centrifuge tubes. Only one tube is opened at a time in
order to minimize chances ofcross contamination between
samples. DNA amplification was accomplished in 96 well
format using either a Zymate II automated PCR system
with an MJ thermal controller or by reagent assembly
and sample loading by a Hamilton Micro Lab 2200 and
thermal cycling on a Perkin-Elmer 9600. Throughput
varied according to the DNA extraction technique. The
extraction efficiencies were evaluated using several
different sample matrices and DNA analytes.
A liquid handling station to rapidly assemble
reagents and sample loading for DNA amplification
by PCR
Werner W. Wilke, Arzu Karabay, Ronald N. Jones
and Larry D. Sutton
Medical Microbiology Division, Department of Pathology,
University of Iowa College of Medicine, Iowa City, IA, USA
DNA analysis based upon gene amplification by the
polymerase chain reaction (PCR) continues to find new
applications in medicine, agriculture, environmental
analysis, and the food, pharmaceutical and biotechnology
industries. Many of these applications require high
throughput and reliability, especially with regard to
prevention of false positives due to carry-over contami-
nation. The performance ofthe Hamilton Micro Lab 2200
to assemble PCR reagents and load samples into micro-
tubes in 96-well format for amplification on a Perkin-
Elmer 9600 thermal controller was evaluated. DNA was
extracted from samples using a Zymate XP system.
Performance was validated by comparing to a Zymate II
automated PCR system which has been evaluated over
the past three years. Washing the Teflon-coated steel
cannula with 5, sodium hypochlorite followed by
copious rinses with distilled water using the peristaltic
pump accessory, adequately eliminated sample carry-
over. The high flow rate (3 ml over 10 seconds per
channel) achievable with the peristaltic pump was
essential to eliminate carry-over ofboth target and bleach
(which inhibited PCR). Up to50 negative controls were
used to assess aerosolization of target; none was detected.
No build up of target DNA overtime was observed. As
configured, the system is capable of assembling over 1800
PCR reactions in an eight hour shift translating into nearly
500 000 reactions per year. At this throughput, use offixed
cannula may save from $5000 to $30000 in disposable
pipette tips.
Validation ofrobotic-automation ofthe fluorescent
microsphere technique for determination of re-
gional blood flow
R. Hecht, S. Raab and K. Messmer
Institute for Surgical Research, LM-University of Munich,
Germany
Determination of regional blood flow (RBF) by means of
fluorescent-labeled microspheres (FM) has been demon-
strated to be an attractive alternative to conventional
radioactive microspheres (RM). However, processing of
tissue samples to completely extract fluorescence from the
tissue is time consuming because it has to be performed
manually. In addition, it presents a source of error.
The authors designed a new sample processing unit (SPU)
which allows the entire processing of the tissue samples
automatically. After digestion of the tissue samples by
exposure to 4 N KOH at 60C for 4 hours and vacuum-
filtration, the extraction of the fluorescent dye is accom-
plished by adding 2(2-ethoxy-ethoxy)-ethyl-acetate and
followed by centrifugation. Zymark Corporation (Hop-
kinton, MA, USA) provided a modified robotic system
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for processing the tissue sample to analyse the fluorescence
of multiple colours present in each sample. For validation
of the FM-method of the new automated SPU, combi-
nations of different RM and FM (0-15 gl) were simul-
taneously injected into the left atrium of six pigs. For all
tissue samples prepared according to an hierarchical
organ dissection scheme (N 301/pro animal: heart 201;
brain 46; kidney 44; skeletal muscle 10), RBF was
calculated based on radioactivity or fluorescence intensity,
respectively.
The RBF determined by FM using the new SPU with
automated measurement corresponded to RM-RBF
values (r > 0"95).
The automated FM method reported allows reliable
determination ofRBF with the advantage of automatically
processing 40 samples/hour and without need of radio-
isotopes.
LABORATORY WORKSTATION
Analysis of cleaning validation samples with the
Zymark BenchMate workstation
Stephen Scypinski, Theodore Sadlowski and John
Baiano
Hoffmann-La Roche, Inc., Nutley, NJ, USA
The performance ofcleaning validation or cleaning assess-
ment studies is necessary to verify that a piece of
pharmaceutical processing equipment is free from con-
tamination from both active substance and cleaning agent
after its use. Cleaning validation is especially important
to the development arena, where it is quite common for
a single blender, mill or tablet press to be utilized in the
production of several products. Therefore, the cleaning of
such processing equipment has become commonplace,
along with the detailed protocols for the proper execution
of the cleaning procedures. Because of the rigours of these
procedures and the complexity of typical equipment
involved, cleaning validation typically results in a
multitude of samples for a single cleaning. These samples
consist of either swabs obtained by wiping a prescribed
area of the machine or rinse samples collected during the
washing of its specified parts. While the methods used to
analyse these samples are usually not very complicated,
the tedium of analysing such a large amount of samples
can be considerable.
The authors have found that such a procedure was an
excellent candidate for automation via the Zymark Bench-
Mate Workstation. BenchMate racks containing 16 x
100 mm test tubes with caps are given to the industrial
pharmacists who perform the cleaning of the equipment
following a prescribed Standard Operating Procedure
(SOP). The tubes are turned to the laboratory containing
swabs or rinse solutions. In the case of solutions, the racks
are placed in the Zymark TurboVap for concentration
followed by placement in the BenchMate for analysis.
Racks containing swab samples are placed immediately
in the BenchMate.
Several products have already been automated by this
procedure, and the authors anticipate no further need to
perform these analyses manually. The generic method and
specific results for several products were presented.
Automated analysis of oral care products by
HPLC using a BenchMate sample preparation
workstation
Anthony J. Wilkes, Gisele Walraven andJean-Marie
Talbot
Colgate Palmolive Company, Research and Development Inc.,
Milmort (Herstal), B 4041 Belgium
Automated methods have been elaborated for the analyses
ofseveral therapeutic agents ofdental creams and mouth-
rinses. Sample weighing, dilution, mixing of liquids by
cycling (mouthrinses) or vortex agitation ofviscous liquids
or pastes (dental creams), addition of internal standards,
filtration of particulate matter, preparation of multi level
calibration standards and injection onto the HPLC
chromatograph was effected using the BenchMate Work-
station. The BenchMate was employed in-line, thus
samples and multi-level calibration standards were freshly
prepared prior to injection and analysis by HPLC.
Operator time was reduced to a minimum and results
were furnished during unattended overnight or weekend
runs. Results obtained using the BenchMate for both
internal and external standard methods were in excellent
agreement with those obtained using the manual pro-
cedures; RSDs were typically less than 2.
Automated determination of trace avermectins in
waste streams
Andrew Lange and Mark Grimaldi
Merck & Co., Inc., Elkton, VA, USA
Production and environmental demands necessitated the
development ofa quick, sensitive assay for analysing trace
avermectins in waste streams. A sensitive, automated assay
that included solid-phase extraction, solvent extraction,
evaporation and derivatization, followed by HPLC
analysis using fluorescence detection was developed. To
this end, several modifications were made to a Zymark
AutoTraceTM Workstation, and custom accessories were
fabricated.
To quantify these trace amounts in aqueous solution, the
AutoTrace was used to extract the avermectins from waste
water using solid-phase extraction. To quantify avermec-
tins adsorbed to solids in waste waters the AutoTrace
Workstation was modified to allow solvent extraction and
injection of samples containing solids. A PTFE adapter
was manufactured to allow stacking of a C-8 solid phase
extraction column and a Florisil clean-up column in
series, combining two steps in the analysis. Specialized
glassware was made to accommodate 20-ml of eluate and
allow the eluate to be evaporated to a residue in an HPLC
vial. This new glassware required modifications to both
the AutoTrace Workstation and TurboVap system. The
TurboVap system was used for drying multiple samples,
and a Shimadzu SIL-10A autosampler was used to
automate the derivatization step.
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The analysis of standards from 20 gg/1 (ppb) to gg/1
have been tested thus far with good correlation between
concentration and peak area, with a correlation coefficient
(R2) of 0"99. The precision ranges from 6-13 (relative
standard deviation) and the detection limit is below
10 ng/1 (ppt).
Extraction of benzoylecgonine from urine samples
using the Zymark RapidTraceTM
William H. Vickery, Francis X. Diamond and
John de Kanel
National Medical Services, Willow Grove, PA, USA
Benzoylecgonine is one of the primary metabolites
excreted in the urine following cocaine exposure. It is this
metabolite which is designated by SAMHSA (Substance
Abuse Mental Health Service Administration formerly
National Institute for Drug Abuse, NIDA) for analysis in
employment and pre-employment situations to determine
if cocaine has been used. Numerous methods have been
published describing methods to extract benzoylecgonine
from urine either by traditional liquid/liquid means or
by solid phase extraction. Liquid/liquid extractions are
time consuming, difficult to automate and require great
analyst skill if they are to produce reproducible and
accurate results. Each manufacturer of solid phase
extraction cartridges has published methods to accomplish
the extraction of benzoylecgonine from urine. For the
purposes of evaluating the Zymark RapidTraceTM
automated extraction workstation, the Applied Separ-
ations’ method published for use with their SpeedTM Scan
ABN cartridges was chosen. The method was programmed
into the RapidTrace
TM software without modification. A
set of 10 Zymark RapidTraceTM sample preparation units
controlled by one personal computer was capable of
extracting benzoylecgonine from 60 urine samples per
hour. The samples were then evaporated to dryness at
40C using a Zymark TurboVap. This step took approxi-
mately 10 minutes. The samples were then derivatized by
reaction with 50 gl /BSTFA with 19/o TMCS) in 50 gl
ethyl acetate for 20 minutes at 70C in a sealed tube. The
samples were then transferred to autosampler vials and
analysed by GC/MS. A technician would spend at least
three hours preparing these extracts manually. The use
of the RapidTrace frees the technician to work on more
productive things such as data review for two of the three
hours.
One millilitre urine samples known to be negative for
cocaine metabolites were spiked with deuterated benzoyl-
ecgonine at a level of 200 ng/ml as an internal standard
and with benzoylecgonine at varying levels to evaluate
the recovery, linearity and carry-over of the extraction
method when performed by the Zymark RapidTrace. The
results from this experiment are presented in the table.
The standards at 75, 150, 300 and 1000 ng/ml were used
to determine back calculated levels for these standards
and to quantitate the controls at 120 and 180 ng ng/ml
as well as levels in various blank samples. A urine sample
was extracted through the procedure after spiking it with
100000 ng/ml benzoylecgonine. Analysis of the blank
samples following this procedure was done to estimate
carry-over. The procedure used was identical to the
Ion Ion Ion
Spike Calculated ratio ratio ratio
ng/ml level, ng/ml 346/240 361/240 361/346
75 78 0"1088 0"2844 2"652
150 142 0"1033 0"2761 2"673
300 300 0"0992 0"3224 3"249
1000 1000 0"0986 0"3088 3"132
120 129 0"1145 0"3085 2"694
180 175 0’1074 0"3253 3"029
5"5 0"6326 0"9166 1"449
0* 15"1 0"0725 0"3483 4"802
5"2 0"1947 0"2934 1"507
* Blank extracted after the 100 000 ng/ml spiked sample extraction.
routine procedure which would be followed for real
samples. No extra manipulative steps were added in an
effort to minimize carry-over. The extract from the
100000 ng/ml sample was not derivatized nor analysed
by GC/MS since potential carry-over on the GC auto
sampler could have confused results.
Under SAMHSA guidelines an affirmative cut-off of
150 ng/ml is used to administratively differentiate positive
samples from negative ones. Irrespective of other data,
samples containing benzoylecgonine below this adminis-
trative level are reported to clients as negative. In addition
to this quantitative test, three ion ratios must be within
20% of values determined for a standard. Direct quanti-
tation of the blank following the 100000 ng/ml spike
yields 15 ng/ml or 0"015% carry-over. Some of this level
is derived from the background noise. The blanks
extracted after relatively low levels of benzoylecgonine
quantitate to approximately 5 ng/ml, for example. These
levels are all far below the administrative cut off of
150 ng/ml. In addition to this, however, the ion ratio test
fails for all the blank runs. Benzoylecgonine cannot even
be identified in these samples, therefore.
AUTOMATION AND COMBINATORIAL
CHEMISTRY
Second-generation robotic synthesizer for peptide,
pseudopeptide and non-peptide libraries
Jean A. Boutin and Jean-Luc Fauchere
Division des Peptides, Institut de Recherches Servier, 92150
Suresnes, France
A second-generation peptide library synthesizer has been
constructed around a Zymark robotic arm. In order to
provide new solutions for the ever-growing field of
combinatorial libraries, it has been designed to handle
gram quantities of resin for the solid phase synthesis of
potentially any type of library.
To ensure a wide molecular diversity, a series of 24
building blocks was used and therefore, the robot synthesis
station is a table hooked with 25 (5 columns of 5) reactors,
slaved to individual gas and waste valves. The 25th reactor
serves as a control permitting the independent but
concomitant synthesis of a single defined product which
is closely analysed by HPLC, mass spectrometry and
nuclear magnetic resonance. Since libraries (i.e. defined
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mixtures of oligomers made up of at least 24 building
blocks) are extremely complex mixtures, with up to several
millions of individual chemicals, a minimum of g (i.e.
2 x 10 beads) per reactor vessel was considered the
absolute requirement to ensure the proper and complete
synthesis of random tetra- to penta peptide libraries, or
of higher oligomer libraries with fixed positions.
Designed to perform the so-called mix-and-divide strategy,
the robot comprises a mixing chamber that functions
as a mixer between each step of the combinatorial
synthesis. This chamber is filled and emptied by a
CombiTip-based hand that ensures the proper and total
transfer of the bead suspension. Finally the instrument
comprises also a section for automatically dissolving the
starting materials (not limited to natural or exotic amino
acids), thus ensuring the maximum stability of the
chemicals before coupling. This section comprises five sets
of 25 tubes in which the dry building blocks are stocked
and five additional devices for large quantities ofcommon
reagents. The robot comprises a set of valves and hands
that handle up to 10 different liquids used in the chemical
reactions or as washing solvents.
This instrument is a unique tool for the iterative synthesis
of defined libraries. More than a 100 different peptide,
pseudopeptide and non-peptide libraries (over 20 million
compounds altogether) have been synthesized in the
authors’ laboratory in the past two years leading to ligands
of therapeutically relevant targets active in the micro to
nanomolar ranges.
reaction blocks are processed by a series of custom-built,
task specific workstations organized in an assembly line
fashion. Compounds are cleaved from each of the 96
individual reaction vessels of the reaction block system
directly into the wells of a standard 96-well microtitre
plate. These plates, with one compound per well, are
readily accepted onto Ontogen’s automated high through-
put screening (HTS) systems. Client/server database
software for inventory control, experiment design, instru-
ment control, HTS data analysis and structure activity
relationship (SAR) studies is written in Visual Basic and
Oracle7. Synthesis of compounds in the OntoBLOCK
system is driven by instrument control language (ICL)
scripts which are generated by the experiment planning
software and integrated within the database system. In
the OntoCODE system, miniature reaction capsules are
electronically coded with a solid state radio frequency tag
and undergo a number of split and recombine synthetic
steps. The OntoCODE tag is electronically read after each
step to maintain a reaction histogram. After the synthetic
steps are completed, the discrete compounds are cleaved
.from the coded capsules into standard 96-well microtitre
plates for HTS, with one compound per well. In both
systems, an automated mass spectrometer processes the
microtitre plates and produces spectra for each com-
pound.
A totally integrated approach to combinatorial
chemistry
Automated preparation and purification ofamides
R. Michael Lawrence, Olga M. Fryszman, Michael
A. Poss, Scott. A. Billet and Harold N. Weller
Bristol-Myers Squibb Company, Princeton, NJ, USA
With ever-increasing pressures on the pharmaceutical
industry to bring innovative products to the marketplace
more quickly, Bristol-Myers Squibb Company is exploring
automated organic synthesis as a means to accelerate the
drug discovery process. To this end, we have developed
an automated solution phase procedure to rapidly prepare
amides. Utilizing a Zymark BenchMate Workstation, up
to 100 reactions can be set up and the resulting products
purified by exploiting the solid phase extraction capabilities
of the BenchMate Workstation. The procedures for
reaction set-up, product purification, analytical sample
preparation and electronic data handling were described
in this presentation.
Automated combinatorial chemistry on solid phase
John F. Cargill
Ontogen Corporation, Carlsbad, CA, USA
High speed solid phase synthesis of diverse, non-peptidyl
small organic molecules in a spatially dispersed combina-
torial library (SDCL) is accomplished with proprietary
automation systems called OntoBLOCK and OntoCODE.
These systems support reagent introduction and removal,
agitation, inert atmosphere, temperature control, pressure
control and vacuum drying. In the OntoBLOCK system,
Peter L. Myers
CombiChem, Inc., La Jolla, CA, USA
Combinatorial chemistry is emerging as one of a series of
technology advances, which over the next decade, could
potentially provide a more efficient and successful
approach to drug discovery. As with the advent of many
new technologies there has been very significant evolution
from the initial creative, but complex, methodologies
which validated the concept to a growing requirement
for a simplifying strategy to leverage its full potential. The
real value of the technology to the medicinal chemist, who
is ultimately responsible for selecting and optimizing lead
structures, lies in the ability to maximize the information
gained in screening combinatorial libraries of molecules
against a wide range of biological targets, and to patent
file composition claims to molecules of most interest, in a
traditional manner.
As these are essential requirements, it is obvious that the
focus in library design and synthesis should be on multi-
parallel synthesis ofsingle compounds (discretes) in multi-
milligram quantities with appropriate QC methods for
purity and confirmation of identity. This is most readily
achieved by making smaller libraries and simultaneously
eliminates the need for complicated tagging and/or
deconvolution strategies which are not always successful
and may complicate the chemical processes.
However, proportionately larger numbers ofsuch libraries
will now be necessary, to ensure that we exploit the
potential diversity open to us. They must be well designed
both for synthesis and more specifically content. Ideally the
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synthetic methodology should also be capable of simple
automation to minimize manpower resource.
Thus CombiChem’s intention as a combinatorial chemistry
company is to develop an integrated package comprising
state of the art combinatorial library synthesis incor-
porating computational software design and instrumen-
tation which together will form the major infrastructure
towards optimal library design and synthesis.
DIVERSOMERTM technology and recent advances
in automated synthesis
S. Hobbs DeWitt’ N. Halim, E. Hogan, A. W.
lIzarnik
Parke-Davis Pharmaceutical Research, Division of Warner-
Lambert Company, Ann Arbor, MI, USA
A. MacDonald and R. Ramage
University of Edinburgh, Department of Chemistry, Edinburgh,
UK
Advances in molecular biology and automation have
revolutionized the testing ofcompounds for drug discovery.
Biologists at Parke-Davis can now test up to 500000
samples in one month. Therefore, traditional methods for
chemically synthesizing compounds one-by-one can no
longer meet the demands of mass screening. The ability
to synthesize multiple compounds in a simultaneous
fashion is the goal of Parke-Davis’ DIVERSOMERTM
technology. Automation of routine and labour-intensive
steps of chemistry is critical to advancing combinatorial
and high throughput synthesis. Although automation has
been extensively used in clinical chemistry and high
throughput screening, it has not been integrated into
synthetic chemistry laboratories. This is largely due to the
fact that chemistry requires individual and precise
manipulations. The objectives ofautomation in chemistry
are not only speed and productivity but also precision in
sample transfers and manipulations.
DIVERSOMERTM technology enables the high through-
put synthesis of organic compounds using both manual
and automated methods. The system design incorporates a
modular approach employing robotic automation to
achieve parallel processing of40 intermediates or products.
Automation and integration has been achieved by
modifying and exploiting commercial software and
hardware products. Representative hardware and soft-
ware includes the DIVERSOMERTM apparatus, a Tecan
robotic sample processor, Microsoft Excel, and MDL
software. The combination of these tools enables a full
range of operations necessary for the generation and
testing ofcompound libraries for combinatorial chemistry
and molecular diversity programs.
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